View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 31, 2018	Jan. 31, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Entity Emerging Growth Company	false
Entity Small Business	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false
Trading Symbol	CL
Entity Common Stock, Shares Outstanding		861,676,494
Entity Well-known Seasoned Issuer	Yes
Entity Shell Company	false
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 56.0

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 15,544	$ 15,454	$ 15,195
Cost of sales	6,313	6,174	6,072
Gross profit	9,231	9,280	9,123
Selling, general and administrative expenses	5,389	5,400	5,143
Other (income) expense, net	148	173	25
Operating profit	3,694	3,707	3,955
Non-service related postretirement costs	87	118	118
Interest (income) expense, net	143	102	99
Income before income taxes	3,464	3,487	3,738
Provision for income taxes	906	1,313	1,152
Net income including noncontrolling interests	2,558	2,174	2,586
Less: Net income attributable to noncontrolling interests	158	150	145
Net income attributable to Colgate-Palmolive Company	$ 2,400	$ 2,024	$ 2,441
Earnings per common share, basic (in dollars per share)	$ 2.76	$ 2.30	$ 2.74
Earnings per common share, diluted (in dollars per share)	$ 2.75	$ 2.28	$ 2.72

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 2,558	$ 2,174	$ 2,586
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	(237)	302	(137)
Retirement plan and other retiree benefit adjustments	38	54	(109)
Gains (losses) on available-for-sale securities	0	0	(1)
Gains (losses) on cash flow hedges	10	(14)	5
Total Other comprehensive income (loss), net of tax	(189)	342	(242)
Total Comprehensive income including noncontrolling interests	2,369	2,516	2,344
Less: Net income attributable to noncontrolling interests	158	150	145
Less: Cumulative translation adjustments attributable to noncontrolling interests	(19)	17	(12)
Total Comprehensive income attributable to noncontrolling interests	139	167	133
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 2,230	$ 2,349	$ 2,211

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Current Assets
Cash and cash equivalents	$ 726	$ 1,535
Receivables (net of allowances of $82 and $77, respectively)	1,400	1,480
Inventories	1,250	1,221
Other current assets	417	403
Total current assets	3,793	4,639
Property, plant and equipment, net	3,881	4,072
Goodwill	2,530	2,218
Other intangible assets, net	1,637	1,341
Deferred income taxes	152	188
Other assets	168	218
Total assets	12,161	12,676
Current Liabilities
Notes and loans payable	12	11
Current portion of long-term debt	0	0
Accounts payable	1,222	1,212
Accrued income taxes	411	354
Other accruals	1,696	1,831
Total current liabilities	3,341	3,408
Long-term debt	6,354	6,566
Deferred income taxes	235	204
Other liabilities	2,034	2,255
Total liabilities	11,964	12,433
Commitments and contingent liabilities
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466
Additional paid-in capital	2,204	1,984
Retained earnings	21,615	20,531
Accumulated other comprehensive income (loss)	(4,188)	(3,855)
Unearned compensation	(3)	(5)
Treasury stock, at cost	(21,196)	(20,181)
Total Colgate-Palmolive Company shareholders’ equity	(102)	(60)
Noncontrolling interests	299	303
Total equity	197	243
Total liabilities and equity	$ 12,161	$ 12,676

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Current Assets
Allowance for doubtful accounts receivable, current	$ 82	$ 77
Shareholders’ Equity
Common Stock, Par Value (in dollars per share)	$ 1	$ 1
Common Stock, Shares Authorized (in shares)	2,000,000,000	2,000,000,000
Common Stock, Shares Issued (in shares)	1,465,706,360	1,465,706,360

Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions

Total

Common Stock

Additional Paid-In Capital

Unearned Compensation

Treasury Stock

Retained Earnings

Accumulated Other Comprehensive Income (Loss)

Noncontrolling Interests

Beginning balance at Dec. 31, 2015

$ 1,466

$ 1,438

$ (12)

$ (18,102)

$ 18,861

$ (3,950)

$ 255

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 2,586

2,441

145

Other comprehensive income (loss), net of tax

(242)

(230)

(12)

Dividends

(1,380)

(128)

Stock-based compensation expense

123

Shares issued for stock options

128

242

Shares issued for restricted stock awards

(60)

Treasury stock acquired

(1,335)

Other

Ending balance at Dec. 31, 2016

1,466

1,691

(7)

(19,135)

19,922

(4,180)

260

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

2,174

2,024

150

Other comprehensive income (loss), net of tax

342

325

Dividends

(1,405)

(124)

Stock-based compensation expense

127

Shares issued for stock options

197

313

Shares issued for restricted stock awards

(34)

Treasury stock acquired

(1,399)

Other

(10)

Ending balance at Dec. 31, 2017

243

1,466

1,984

(5)

(20,181)

20,531

(3,855)

303

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

2,558

2,400

158

Other comprehensive income (loss), net of tax

(189)

(170)

(19)

Dividends

(1,448)

(143)

Stock-based compensation expense

109

Shares issued for stock options

137

190

Shares issued for restricted stock awards

(31)

Treasury stock acquired

(1,238)

Other

^[1]

132

(163)

Ending balance at Dec. 31, 2018

$ 197

$ 1,466

$ 2,204

$ (3)

$ (21,196)

$ 21,615

$ (4,188)

$ 299

[1]	(1) As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the TCJA to Retained earnings. See Note 2, Summary of Significant Accounting Policies for additional information.

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating Activities
Net income including noncontrolling interests	$ 2,558	$ 2,174	$ 2,586
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	511	475	443
Restructuring and termination benefits, net of cash	(7)	91	(9)
Stock-based compensation expense	109	127	123
Gain on sale of land in Mexico	0	0	(97)
Charge for U.S. tax reform	80	275	0
Deferred income taxes	27	108	56
Voluntary benefit plan contributions	(67)	(81)	(53)
Cash effects of changes in:
Receivables	(79)	(15)	(17)
Inventories	(58)	(8)	(4)
Accounts payable and other accruals	18	(96)	100
Other non-current assets and liabilities	(36)	4	13
Net cash provided by operations	3,056	3,054	3,141
Investing Activities
Capital expenditures	(436)	(553)	(593)
Sale of property and non-core product lines	1	44	0
Purchases of marketable securities and investments	(169)	(347)	(336)
Proceeds from sale of marketable securities and investments	156	391	378
Proceeds from sale of land in Mexico	0	0	60
Payment for acquisitions, net of cash acquired	(728)	0	(5)
Other	6	(6)	(3)
Net cash used in investing activities	(1,170)	(471)	(499)
Financing Activities
Principal payments on debt	(7,355)	(4,808)	(7,274)
Proceeds from issuance of debt	7,176	4,779	7,438
Dividends paid	(1,591)	(1,529)	(1,508)
Purchases of treasury shares	(1,238)	(1,399)	(1,335)
Proceeds from exercise of stock options	329	507	446
Net cash used in financing activities	(2,679)	(2,450)	(2,233)
Effect of exchange rate changes on Cash and cash equivalents	(16)	87	(64)
Net (decrease) increase in Cash and cash equivalents	(809)	220	345
Cash and cash equivalents at beginning of year	1,535	1,315	970
Cash and cash equivalents at end of year	726	1,535	1,315
Supplemental Cash Flow Information
Income taxes paid	847	1,037	932
Interest paid	$ 194	$ 150	$ 162

Nature of Operations

12 Months Ended

Dec. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes and mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, professional skin care products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. These products are sold primarily to a variety of traditional and e-commerce retailers, wholesalers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers. Principal global and regional trademarks include Colgate, Palmolive, elmex, Tom’s of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet.

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:



	2018		2017		2016
Oral Care	47	%	48	%	47	%
Personal Care	20	%	19	%	20	%
Home Care	18	%	18	%	18	%
Pet Nutrition	15	%	15	%	15	%
Total	100	%	100	%	100	%

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2018 and 2017, equity method investments included in Other assets in the Consolidated Balance Sheets were $46 and $42, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves and charges related to U.S. tax reform (see Note 11, Income Taxes). Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates. Revenue Recognition The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to direct the “use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses. Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,255, $1,183 and $1,140 for the years ended December 31, 2018, 2017 and 2016, respectively. Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Inventories The cost of approximately 75% of inventories is determined using the first-in, first-out (“FIFO”) method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method, which is stated at the lower of cost or market. Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses. Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit. Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes. Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations. Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to estimate the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans. Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. Recent Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-15, “Intangibles–Goodwill and Other–Internal–Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis and does not expect the guidance to have a material impact on the Company’s Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-14, “Compensation–Retirement Benefits–Defined Benefit Plans–General (Topic 715): Disclosure Framework–Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning in the year ending December 31, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In February 2018, the FASB issued ASU No. 2018-02, “Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”), which permits the reclassification of stranded tax effects resulting from the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) from Accumulated other comprehensive income (loss) to Retained earnings. This new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted, and must be applied either in the period of adoption or retrospectively to periods in which the effects of the TCJA are recognized. The Company elected to adopt this new guidance early, beginning on January 1, 2018, and reclassified $163 during the first quarter of 2018. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. In October 2018, the FASB issued ASU No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance is effective for the Company beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12, with early adoption permitted. The new guidance is required to be applied on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In May 2017, the FASB issued ASU No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a stock-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2018 and did not impact the Company’s Consolidated Financial Statements, as it is not the Company’s practice to change either the terms or the conditions of stock-based payment awards once they are granted. In March 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. The non-service related components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement was adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization was adopted on a prospective basis. Effective January 1, 2018, as required, the Company adopted this standard on a retrospective basis. As permitted by the new guidance, the Company used the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the basis for applying the retrospective presentation requirements. As a result, for all periods presented, only the service related component of pension and other postretirement benefit costs is included in Operating profit. For the years ended December 31, 2017 and 2016, the Company reclassified $118 and $118, respectively, of non-service related components of pension and other postretirement costs, which was previously deducted from Operating profit, to a new line item, “Non-service related postretirement costs,” which is below Operating profit. Adoption of this standard had no effect on Net income attributable to Colgate-Palmolive Company, Earnings per common share or Cash flow. In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements. In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance did not have an impact on the Company’s Consolidated Financial Statements. In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance was effective for the Company on January 1, 2018. This new guidance did not have an impact on the Company’s Consolidated Financial Statements. In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases.” The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, and enhanced disclosures about the Company’s leasing arrangements. Substantially all of the Company’s leases are considered operating leases and, as such, under accounting standards in effect at December 31, 2018, were not recognized on the Company’s Consolidated Balance Sheets as of December 31, 2018 and 2017. In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” to clarify the implementation guidance and ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements.” This updated guidance provided an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. The Company adopted the new standard beginning on January 1, 2019 and elected the optional transition method with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard is expected to result in the recognition of right-of-use assets of approximately $450 and liabilities of approximately $575, with no material cumulative effect adjustment to its Consolidated Balance Sheet as of the date of adoption. Adoption of the new standard will not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments, which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard was effective for the Company beginning on January 1, 2018 and did not have an impact on the Company’s Consolidated Financial Statements. In May 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company adopted the new standard on January 1, 2018, on a “modified retrospective” basis, which did not have a material impact on the Company’s Consolidated Financial Statements. As required, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the 2018 opening balance of retained earnings. Results for periods beginning on or after January 1, 2018 are presented under Topic 606, “Revenue from Contracts with Customers,” while prior period amounts are not adjusted and continue to be reported in accordance with the prior accounting guidance under Topic 605, “Revenue Recognition.” Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Acquisitions and Divestitures

12 Months Ended

Dec. 31, 2018

Business Combinations [Abstract]

Acquisitions and Divestitures

Acquisitions

In January 2018, the Company acquired all of the outstanding equity interests of Physicians Care Alliance, LLC (“PCA Skin”) and Elta MD Holdings, Inc. (“Elta MD”), professional skin care businesses, for aggregate cash consideration of approximately $730. With these acquisitions, the Company entered the professional skin care category, which complements its existing global personal care businesses and resulted in the recognition of additional goodwill.

Total purchase price consideration of $730 has been allocated to the net assets acquired based on their respective estimated fair values as follows:



Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	8
Other current assets	8
Other intangible assets	369
Goodwill	397
Other current liabilities	(6		)
Deferred income taxes	(46		)
Fair value of net assets acquired	$	730

Other intangible assets acquired primarily include trademarks of $231 with useful lives of 25 years and customer relationships of $133 with useful lives ranging from 12 to 13 years.

Goodwill of $397 was allocated to the North America segment. The Company expects that approximately 45% of the goodwill will be deductible for tax purposes.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

Sale of Land in Mexico

In September 2016, the Company’s Mexican subsidiary completed the sale to the United States of America of the Mexico City site on which its commercial operations, technology center and soap production facility were previously located and received $60 as the third and final installment of the sale price. The total sale price (including the third installment and the previously received first and second installments) was $120. The Company recognized a pretax gain of $97 ($63 aftertax or $0.07 per diluted share) in the third quarter of 2016, net of costs primarily related to site preparation.

Restructuring and Related Implementation Charges

12 Months Ended

Dec. 31, 2018

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a restructuring program (the “Global Growth and Efficiency Program”). The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Initiatives under the Global Growth and Efficiency Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

Including the most recent expansion, cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019.

The pretax charges resulting from the Global Growth and Efficiency Program are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (45%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (5%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (30%) and the implementation of new strategies (20%). Over the course of the Global Growth and Efficiency Program, it is currently estimated that approximately 80% of the charges will result in cash expenditures.

The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (20%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 4,000 to 4,400 positions from the Company’s global employee workforce.

For the years ended December 31, 2018, 2017 and 2016, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:



	2018		2017		2016
Cost of sales	$	31	$	75	$	46
Selling, general and administrative expenses	33		86		77
Other (income) expense, net	88		152		93
Non-service related postretirement costs	9		20		12
Total Global Growth and Efficiency Program charges, pretax	$	161	$	333	$	228

Total Global Growth and Efficiency Program charges, aftertax	$	125	$	246	$	168

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:



							Program-to-date
	2018		2017		2016		Accumulated Charges
North America	18	%	23	%	35	%	18	%
Latin America	10	%	2	%	5	%	4	%
Europe	(2	)%	21	%	12	%	20	%
Asia Pacific	13	%	5	%	4	%	4	%
Africa/Eurasia	5	%	3	%	14	%	6	%
Hill’s Pet Nutrition	19	%	6	%	7	%	8	%
Corporate	37	%	40	%	23	%	40	%
Total	100	%	100	%	100	%	100	%

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,722 ($1,278 aftertax) in connection with the implementation of various projects as follows:



	Cumulative Charges
	as of December 31, 2018
Employee-Related Costs	$	681
Incremental Depreciation	92
Asset Impairments	52
Other	897
Total	$	1,722

The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following table summarizes the activity for the restructuring and related implementation charges, in the respective periods, discussed above and the related accruals:



	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at January 1, 2016	$	84		$	—		$	—		$	131		$	215
Charges	61			9			20			138			228
Cash payments	(84		)	—			—			(153		)	(237		)
Charges against assets	(4		)	(9		)	(20		)	—			(33		)
Foreign exchange	(1		)	—			—			—			(1		)
Other	—			—			—			9			9
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	163			10			9			151			333
Cash payments	(74		)	—			—			(170		)	(244		)
Charges against assets	(21		)	(10		)	(9		)	—			(40		)
Foreign exchange	3			—			—			1			4
Other	—			—			—			—			—
Balance at December 31, 2017	$	127		$	—		$	—		$	107		$	234
Charges	53			2			16			90			161
Cash payments	(107		)	—			—			(60		)	(167		)
Charges against assets	(9		)	(2		)	(16		)	—			(27		)
Foreign exchange	(4		)	—			—			—			(4		)
Other	—			—			—			5			5
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $9, $21 and $4 for the years ended December 31, 2018, 2017 and 2016, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits for additional information).

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the years ended December 31, 2018, 2017 and 2016 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $42, $145 and $116, respectively, and contract termination costs and charges resulting directly from exit activities of $48, $6 and $21, respectively. These charges were expensed as incurred. Also included in Other charges for the years ended December 31, 2018, 2017 and 2016 are other exit costs of $0, $0 and $1, respectively, related to the consolidation of facilities.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

The net carrying value of Goodwill as of December 31, 2018 and 2017 by segment was as follows:



	2018		2017
Oral, Personal and Home Care
North America	$	733	$	343
Latin America	220		256
Europe	1,302		1,333
Asia Pacific	185		190
Africa/Eurasia	75		81
Total Oral, Personal and Home Care	2,515		2,203
Pet Nutrition	15		15
Total Goodwill	$	2,530	$	2,218

The change in the amount of Goodwill during 2018 is primarily due to the acquisitions of PCA Skin and Elta MD (See Note 3, Acquisitions and Divestitures for further information), which resulted in the recognition of Goodwill in the amount of $397, and the impact of foreign currency translation.

Other intangible assets as of December 31, 2018 and 2017 were comprised of the following:



	2018							2017
	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Trademarks	$	771	$	(358	)	$	413	$	547	$	(337	)	$	210
Other finite life intangible assets	390		(133		)	257		249		(103		)	146
Indefinite life intangible assets	967		—			967		985		—			985
Total Other intangible assets	$	2,128	$	(491	)	$	1,637	$	1,781	$	(440	)	$	1,341

The changes in the net carrying amounts of Other intangible assets during 2018 and 2017 were primarily due to amortization expense of $59 and $35, respectively, as well as the impact of foreign currency translation. In addition, in 2018, Trademarks included $231 and Other finite life intangible assets included customer relationships of $133 acquired in connection with the acquisitions of PCA Skin and Elta MD (See Note 3, Acquisitions and Divestitures for further information). Annual estimated amortization expense for each of the next five years is expected to be approximately $50.

Long-Term Debt and Credit Facilities

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Long-Term Debt and Credit Facilities

Long-term debt consisted of the following at December 31:



	Weighted Average Interest Rate	Maturities			2018		2017
Notes	2.8%	2019	-	2078	$	5,820	$	6,542
Commercial paper	2.5%	2019			534		24
					6,354		6,566
Less: Current portion of long-term debt					—		—
Total					$	6,354	$	6,566

The weighted-average interest rate on short-term borrowings included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2018 and 2017 was 5.3% and 2.8%, respectively.

The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding such obligations, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2018, were as follows:



Years Ended December 31,
2019	$	—
2020	249
2021	298
2022	886
2023	893
Thereafter	2,422

The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.

The Company’s debt issuances support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the fourth quarter of 2017, the Company issued $400 of five-year notes at a fixed rate of 2.25%. During the third quarter of 2017, the Company issued $500 of thirty-year notes at a fixed rate of 3.70%. The debt issuances in 2017 were under the Company’s shelf registration statement. Proceeds from the debt issuances in 2017 were used for general corporate purposes which included the retirement of commercial paper borrowings.

At December 31, 2018, the Company had access to unused domestic and foreign lines of credit of $3,023 (including under the facility discussed below) and could also issue medium-term notes pursuant to an effective shelf registration statement. In November 2018, the Company amended and restated its five-year revolving credit facility, on substantially similar terms, for a five-year term expiring November 2023 and increasing the facility’s capacity to $2,650. Commitment fees related to the credit facility are not material.

Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

Fair Value Measurements and Financial Instruments

12 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.

Valuation Considerations

Assets and liabilities carried at fair value are classified as follows:

Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.

Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).

Interest Rate Risk

The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).

Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as resins, pulp, essential oils, tropical oils, tallow, poultry, corn and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2018 and December 31, 2017:



	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		12/31/18		12/31/17			12/31/18		12/31/17
Interest rate swap contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	—
Interest rate swap contracts	Other assets	—		—		Other liabilities	8		7
Foreign currency contracts	Other current assets	20		25		Other accruals	8		20
Foreign currency contracts	Other assets	—		—		Other liabilities	21		46
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	20	$	25		$	38	$	73

Other financial instruments
Marketable securities	Other current assets	$	10	$	14
Total other financial instruments		$	10	$	14

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2018 and 2017. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2018 and 2017, was $6,434 and $6,799, respectively, and the related carrying value was $6,354 and $6,566, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair Value Hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during each period presented was as follows:



	2018									2017
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at December 31,	$	327		$	900		$	1,227		$	1,231		$	1,000		$	2,231
Gain (loss) on derivatives	(1		)	(2		)	(3		)	(7		)	(9		)	(16		)
Gain (loss) on hedged items	1			2			3			7			9			16

Cash Flow Hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during each period presented was as follows:



	2018								2017
	Foreign Currency Contracts			Commodity Contracts		Total			Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at December 31,	$	782		$	14	$	796		$	702		$	—	$	702
Gain (loss) recognized in OCI	10			—		10			(25		)	—		(25		)
Gain (loss) reclassified into Cost of sales	(4		)	1		(3		)	(3		)	—		(3		)

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is generally expected to be recognized in Cost of sales within the next twelve months.

Net Investment Hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during each period presented was as follows:



	2018									2017
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at December 31,	$	482		$	1,396		$	1,878		$	478		$	601		$	1,079
Gain (loss) on instruments	33			93			126			(71		)	(112		)	(183		)
Gain (loss) on hedged items	(33		)	(93		)	(126		)	71			112			183

Capital Stock and Stock-Based Compensation Plans

12 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Capital Stock and Stock-Based Compensation Plans

Preference Stock

The Company has the authority to issue 50,262,150 shares of preference stock.

Stock Repurchases

On June 18, 2018, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program (the “2018 Program”), which replaced a previously authorized share repurchase program (the “2015 Program”). The Company commenced repurchases of shares of the Company’s common stock under the 2018 Program beginning June 19, 2018. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $1,238 during 2018 under the 2018 Program and 2015 Program.

The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.

A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:



	Common Stock Outstanding		Treasury Stock
Balance, January 1, 2016	892,738,518		572,967,842

Common stock acquired	(19,271,304	)	19,271,304
Shares issued for stock options	8,536,639		(8,536,639	)
Shares issued for restricted stock units and other	1,105,110		(1,105,110	)
Balance, December 31, 2016	883,108,963		582,597,397

Common stock acquired	(19,185,828	)	19,185,828
Shares issued for stock options	9,670,988		(9,670,988	)
Shares issued for restricted stock units and other	1,106,995		(1,106,995	)
Balance, December 31, 2017	874,701,118		591,005,242

Common stock acquired	(18,786,897	)	18,786,897
Shares issued for stock options	6,040,920		(6,040,920	)
Shares issued for restricted stock units and other	957,651		(957,651	)
Balance, December 31, 2018	862,912,792		602,793,568

Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.

The Company has one incentive compensation plan pursuant to which it issues restricted stock units and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $109, $127 and $123 for the years ended December 31, 2018, 2017 and 2016, respectively. The total income tax benefit recognized on stock-based compensation, excluding excess tax benefits discussed below, was approximately $25, $42 and $40 for the years ended December 31, 2018, 2017 and 2016, respectively.

Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2018, 2017 and 2016 was $9.48, $8.37 and $8.10, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:



	2018		2017		2016
Expected term of options	4.5 years		4.5 years		4.5 years
Expected volatility rate	17.7	%	16.0	%	16.7	%
Risk-free interest rate	2.8	%	1.8	%	1.2	%
Expected dividend yield	2.5	%	2.2	%	2.1	%

The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.

Restricted Stock Units

The Company grants restricted stock unit awards, including long-term incentive awards, to officers and other employees. Under the Company’s long-term incentive plan, awards are granted following a three-year performance period. Awards vest at the end of the restriction period, which is three years from the date of grant. As of December 31, 2018, approximately 9,186,000 shares of common stock were available for future restricted stock unit awards.

A summary of restricted stock unit activity during 2018 is presented below:



	Shares (in thousands)		Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 2018	2,730		$	70
Activity:
Granted	814		69
Vested	(901	)	65
Forfeited	(169	)	70
Restricted stock units as of December 31, 2018	2,474		$	71

As of December 31, 2018, there was $45 of total unrecognized compensation expense related to unvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during the years ended December 31, 2018, 2017 and 2016 was $55, $66 and $61, respectively.

Stock Options

The Company issues non-qualified stock options to non-employee directors, officers and other employees. Stock options generally have a contractual term of six years and vest over three years. As of December 31, 2018, 15,604,000 shares of common stock were available for future stock option grants.

A summary of stock option activity during 2018 is presented below:



	Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Intrinsic Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2018	40,979		$	65
Granted	6,290		68
Exercised	(6,669	)	55
Forfeited or expired	(890	)	71
Options outstanding, December 31, 2018	39,710		67		3	$	1,457
Options exercisable, December 31, 2018	26,420		$	66	3	$	1,457

As of December 31, 2018, there was $38 of total unrecognized compensation expense related to unvested options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2018, 2017 and 2016 was $92, $201 and $221, respectively.

The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2018, 2017 and 2016 were $12, $47 and $59, respectively. Through December 31, 2016 these amounts were recognized in equity and were reported as a financing cash flow. Effective January 1, 2017, as a result of the required adoption of ASU No. 2016-09, excess tax benefits from stock-based compensation have been recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from options exercised for the years ended December 31, 2018, 2017 and 2016 were $329, $507 and $386, respectively.

Employee Stock Ownership Plan	12 Months Ended
Employee Stock Ownership Plan	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan In 1989, the Company expanded its Employee Stock Ownership Plan (“ESOP”) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2018 and 2017, there were 15,806,529 and 18,400,412 shares of common stock, respectively, outstanding and issued to the Company’s ESOP. During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2018, the ESOP had outstanding borrowings from the Company of $3, which represents unearned compensation shown as a reduction in Shareholders’ equity. Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2018, 13,237,788 shares of common stock had been released and allocated to participant accounts and 2,568,741 shares of common stock were available for future allocation to participant accounts. Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity. Annual expense related to the ESOP was $0 in 2018, 2017 and 2016. The Company paid dividends on the shares held by the ESOP of $29 in 2018, $32 in 2017 and $35 in 2016. The Company contributed to the ESOP $0 in 2018, 2017 and 2016.

Retirement Plans and Other Retiree Benefits

12 Months Ended

Dec. 31, 2018

Retirement Benefits [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans

The Company and certain of its U.S. and foreign subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings.

In the U.S., effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment.

In the Company’s principal U.S. plans and certain funded foreign plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows:



	United States		International
Asset Category
Equity securities	22	%	37	%
Fixed income securities	60	%	43	%
Real estate and other investments	18	%	20	%
Total	100	%	100	%

At December 31, 2018 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States			International		Other Retiree Benefit Plans

Cash and cash equivalents	Level 1	$	29		$	9	$	1
U.S. common stocks	Level 1	75			3		3
International common stocks	Level 1	—			4		—
Pooled funds⁽¹⁾	Level 1	106			82		4
Fixed income securities⁽²⁾	Level 2	865			24		28
Guaranteed investment contracts⁽³⁾	Level 2	1			51		—
		1,076			173		36
Investments valued using NAV per share⁽⁴⁾
Domestic, developed and emerging markets equity funds		229			134		8
Fixed income funds⁽⁵⁾		116			173		4
Hedge funds⁽⁶⁾		56			6		2
Multi-Asset funds⁽⁷⁾		94			2		3
Real estate funds⁽⁸⁾		39			22		1
		534			337		18

Other assets and liabilities, net⁽⁹⁾		(42		)	—		—
Total Investments		$	1,568		$	510	$	54

At December 31, 2017 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States			International		Other Retiree Benefit Plans

Cash and cash equivalents	Level 1	$	21		$	11	$	—
U.S. common stocks	Level 1	127			4		—
International common stocks	Level 1	—			3		—
Pooled funds⁽¹⁾	Level 1	138			94		—
Fixed income securities⁽²⁾	Level 2	843			24		—
Guaranteed investment contracts⁽³⁾	Level 2	1			53		—
		1,130			189		—
Investments valued using NAV per share⁽⁴⁾
Domestic, developed and emerging markets equity funds		350			189		—
Fixed income funds⁽⁵⁾		122			167		—
Hedge funds⁽⁶⁾		82			5		—
Multi-Asset funds⁽⁷⁾		115			3		—
Real estate funds⁽⁸⁾		38			22		—
		707			386		—

Other assets and liabilities, net⁽⁹⁾		(25		)	—		—
Total Investments		$	1,812		$	575	$	—

_______


⁽¹⁾	Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.


⁽²⁾	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2018 and 2017, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.


⁽³⁾	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.

⁽⁴⁾

Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly.


⁽⁵⁾	Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.


⁽⁶⁾	Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.


⁽⁷⁾	Multi-Asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.


⁽⁸⁾	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.


⁽⁹⁾	This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.

Equity securities in the U.S. plans include investments in the Company’s common stock representing 5% and 7% of U.S. plan assets at December 31, 2018 and December 31, 2017, respectively. In 2018 and 2017, the U.S. plans sold 384,004 and 0 shares, respectively, of the Company’s common stock to the Company. No shares of the Company’s stock were purchased by the U.S. plans in 2018 or 2017. The plans received dividends on the Company’s common stock of $3 in each of 2018 and 2017.

Other Retiree Benefits

The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.

The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:



	Pension Plans												Other Retiree Benefit Plans
	2018			2017			2018			2017			2018			2017
	United States						International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	2,363		$	2,298		$	847		$	800		$	960		$	923
Service cost	1			1			14			16			16			13
Interest cost	86			94			21			22			38			40
Participants’ contributions	—			—			2			2			—			—
Acquisitions/plan amendments	—			—			4			(6		)	—			—
Actuarial loss (gain)	(139		)	110			(11		)	(11		)	(88		)	21
Foreign exchange impact	—			—			(40		)	72			(5		)	3
Termination benefits⁽¹⁾	9			24			—			—			—			(3		)
Curtailments and settlements	(4		)	—			(7		)	(11		)	—			—
Benefit payments	(169		)	(164		)	(42		)	(36		)	(45		)	(37		)
Other	—			—			(1		)	(1		)	—			—
Benefit obligations at end of year	$	2,147		$	2,363		$	787		$	847		$	876		$	960
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,812		$	1,646		$	575		$	509		$	—		$	—
Actual return on plan assets	(101		)	225			(16		)	42			(1		)	—
Company contributions	30			105			27			30			100			37
Participants’ contributions	—			—			3			2			—			—
Foreign exchange impact	—			—			(29		)	40			—			—
Settlements and acquisitions	(4		)	—			(7		)	(11		)	—			—
Benefit payments	(169		)	(164		)	(42		)	(36		)	(45		)	(37		)
Other	—			—			(1		)	(1		)	—			—
Fair value of plan assets at end of year	$	1,568		$	1,812		$	510		$	575		$	54		$	—
Funded Status
Benefit obligations at end of year	$	2,147		$	2,363		$	787		$	847		$	876		$	960
Fair value of plan assets at end of year	1,568			1,812			510			575			54			—
Net amount recognized	$	(579	)	$	(551	)	$	(277	)	$	(272	)	$	(822	)	$	(960	)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	—		$	—		$	6		$	22		$	—		$	—
Current liabilities	(26		)	(24		)	(12		)	(13		)	(46		)	(44		)
Noncurrent liabilities	(553		)	(527		)	(271		)	(281		)	(776		)	(916		)
Net amount recognized	$	(579	)	$	(551	)	$	(277	)	$	(272	)	$	(822	)	$	(960	)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	$	940		$	911		$	226		$	209		$	239		$	338
Transition/prior service cost	1			1			6			1			(1		)	(1		)
	$	941		$	912		$	232		$	210		$	238		$	337
Accumulated benefit obligation	$	2,090		$	2,293		$	731		$	787		$	—		$	—



	Pension Plans								Other Retiree Benefit Plans
	2018		2017		2018		2017		2018		2017
	United States				International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.38	%	3.73	%	2.80	%	2.53	%	4.43	%	3.80	%
Long-term rate of return on plan assets	6.60	%	6.60	%	4.06	%	4.04	%	6.60	%	6.60	%
Long-term rate of compensation increase	3.50	%	3.50	%	2.86	%	2.79	%	3.50	%	3.50	%
ESOP growth rate	—	%	—	%	—	%	—	%	10.00	%	10.00	%
Medical cost trend rate of increase	—	%	—	%	—	%	—	%	6.00	%	6.00	%

_________


⁽¹⁾	Represents pension and other retiree benefit enhancements incurred in 2018 and 2017 pursuant to the Global Growth and Efficiency Program.

The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its long-term rate of return on plan assets on an annual basis. In determining the long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed rate of return as of December 31, 2018 for the U.S. plans was 6.60%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were (5)%, 5%, 8%, 6%, and 7%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2018 weighted-average rate of return of 4.06%.

The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00% in 2019 to 4.75% by 2024, remaining at 4.75% for the years thereafter. Changes in the assumed rate can have a significant effect on amounts reported. A 1% change in the assumed medical cost trend rate would have the following approximate effect:



	One percentage point
	Increase		Decrease
Accumulated postretirement benefit obligation	$	115	$	(93	)
Total of service and interest cost components	10		(7		)

Expected mortality is a key assumption in the measurement of pension and other postretirement benefit obligations. For the Company’s U.S. plans, this assumption was updated as of December 31, 2016 in order to reflect the Society of Actuaries’ updated mortality improvement scale published in October 2016. This resulted in a decrease of 1% and 2% to the benefit obligations for the Company’s U.S. pension plans and other postretirement benefits, respectively.

Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:



	Years Ended December 31,
	2018		2017
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	2,882	$	2,834
Fair value of plan assets	2,007		1,992

Accumulated benefit obligation	2,689		2,641
Fair value of plan assets	1,924		1,905

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:



	Pension Plans																		Other Retiree Benefit Plans
	2018			2017			2016			2018			2017			2016			2018			2017			2016
	United States									International
Components of Net Periodic Benefit Cost
Service cost	$	1		$	1		$	1		$	14		$	16		$	16		$	16		$	13		$	13
Interest cost	86			94			105			21			22			25			38			40			43
Annual ESOP allocation	—			—			—			—			—			—			—			—			—
Expected return on plan assets	(115		)	(111		)	(109		)	(21		)	(22		)	(23		)	(2		)	—			(1		)
Amortization of transition and prior service costs (credits)	—			—			—			—			—			—			—			—			—
Amortization of actuarial loss	47			48			41			8			10			8			14			13			14
Net periodic benefit cost	$	19		$	32		$	38		$	22		$	26		$	26		$	66		$	66		$	69
Other postretirement charges	9			24			3			2			4			11			—			(3		)	1
Total pension cost	$	28		$	56		$	41		$	24		$	30		$	37		$	66		$	63		$	70
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	3.73		%	4.27		%	4.93		%	2.53		%	2.59		%	3.17		%	3.80		%	4.41		%	4.97		%
Long-term rate of return on plan assets	6.60		%	6.80		%	6.80		%	4.04		%	4.14		%	4.62		%	6.60		%	6.80		%	6.80		%
Long-term rate of compensation increase	3.50		%	3.50		%	3.50		%	2.79		%	2.58		%	2.78		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%	—		%	—		%	—		%	10.00		%	10.00		%	10.00		%
Medical cost trend rate of increase	—		%	—		%	—		%	—		%	—		%	—		%	6.00		%	6.33		%	6.67		%

Effective January 1, 2018, as required, the Company adopted ASU No. 2017-07, “Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” on a retrospective basis. As a result, for all periods presented, only the service related component of pension and other postretirement benefit costs is included in Operating profit. The non-service related components (interest cost, expected return on assets and amortization of actuarial gains and losses) are included in a new line item, “Non-service related postretirement costs,” which is below Operating profit. Adoption of this standard had no effect on Net income attributable to Colgate-Palmolive Company, Earnings per common share or Cash flow. See Note 2, Summary of Significant Accounting Policies to the Consolidated Financial Statements for additional information.

Other postretirement charges in 2018, 2017 and 2016 include pension and other benefit enhancements amounting to $9, $21 and $4 respectively, incurred pursuant to the Global Growth and Efficiency Program. Other postretirement charges in 2018 and 2017 also includes charges of $2 and $4, respectively, in part due to retirements under the Global Growth and Efficiency Program.

The Company made voluntary contributions of $67, $81 and $53 in 2018, 2017 and 2016, respectively, to its U.S. retirement plans.

The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows:



	Pension Plans		Other Retiree Benefit Plans
Net actuarial loss	$	60	$	11
Net transition and prior service cost	—		—

Expected Contributions and Benefit Payments

Management’s best estimate of voluntary contributions the Company will make to its U.S. postretirement plans for the year ending December 31, 2019 is approximately $100. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.

Total benefit payments to be paid to participants for the year ending December 31, 2019 from the Company’s assets are estimated to be approximately $61. Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows:



	Pension Plans
Years Ended December 31,	United States		International		Other Retiree Benefit Plans		Total
2019	$	149	$	35	$	47	$	231
2020	146		35		47		228
2021	147		37		48		232
2022	151		36		48		235
2023	151		40		49		240
2024-2028	736		217		256		1,209

Income Taxes

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Income Taxes

The components of Income before income taxes are as follows for the years ended December 31:



	2018		2017		2016
United States	$	1,175	$	1,072	$	1,191
International	2,289		2,415		2,547
Total Income before income taxes	$	3,464	$	3,487	$	3,738

The Provision for income taxes consists of the following for the years ended December 31:



	2018		2017		2016
United States	$	248	$	338	$	395
International	658		975		757
Total Provision for income taxes	$	906	$	1,313	$	1,152

Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:



	2018			2017			2016
Goodwill and intangible assets	$	2		$	135		$	18
Property, plant and equipment	(15		)	84			(3		)
Pension and other retiree benefits	(7		)	(192		)	—
Stock-based compensation	9			(28		)	15
Tax credits and tax loss carryforwards	(4		)	(4		)	5
Deferred withholding tax	(100		)	(119		)	—
Other, net	62			16			(106		)
Total deferred tax benefit (provision)	$	(53	)	$	(108	)	$	(71	)

The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:



Percentage of Income before income taxes	2018		2017		2016
Tax at United States statutory rate	21.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	1.0		0.5		0.5
Earnings taxed at other than United States statutory rate	4.5		(3.4	)	(2.7	)
Charge for U.S. tax reform⁽¹⁾	2.3		7.9		—
Excess tax benefits from stock-based compensation⁽²⁾	(0.3	)	(1.4	)	—
Foreign Tax Credit Carryback⁽⁵⁾	(1.7	)	—		—
(Benefit) charge for foreign tax matters⁽³⁾	(0.4	)	—		(0.8	)
(Benefit) from Venezuela remeasurement⁽⁴⁾	—		—		(5.6	)
Tax charge on incremental repatriation of foreign earnings⁽⁴⁾	—		—		5.6
Other, net	(0.2	)	(0.9	)	(1.2	)
Effective tax rate	26.2	%	37.7	%	30.8	%

_________

⁽¹⁾

On December 22, 2017, the TCJA was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA using information and estimates available as of February 15, 2018, the date on which the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective.

⁽²⁾

As a result of adopting ASU No. 2016-09 “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” effective January 1, 2017, the Company recognized excess tax benefits from stock-based compensation of $12 and $47 (resulting from an increase in the fair value of an award from the grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the years ended December 31, 2018 and 2017, respectively. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits from stock-based compensation recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits from stock-based compensation were recognized in equity. See Note 2, Summary of Significant Accounting Policies - Recent Accounting Pronouncements for additional information.


⁽³⁾	The benefit from a tax matter in 2016 relates to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions.

⁽⁴⁾

The effective tax rate in 2016 included a $210 U.S. income tax benefit principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. Although, effective December 31, 2015, the operating results of the Company’s Venezuelan subsidiary (“CP Venezuela”) are no longer included in the Company’s Consolidated Financial Statements, under current tax rules, the Company is required to continue including CP Venezuela’s results in its consolidated U.S. federal income tax return. In order to fully utilize the above mentioned $210 tax benefit in 2016, the Company repatriated an incremental $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210.


⁽⁵⁾	In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.

The components of deferred tax assets (liabilities) are as follows at December 31:



	2018			2017
Deferred tax liabilities:
Goodwill and intangible assets	$	(344	)	$	(311	)
Property, plant and equipment	(311		)	(306		)
Deferred withholding tax	(181		)	(119		)
Other	(75		)	(63		)
Total deferred tax liabilities	(911		)	(799		)
Deferred tax assets:
Pension and other retiree benefits	354			375
Tax credits and tax loss carryforwards	89			48
Accrued liabilities	180			197
Stock-based compensation	95			90
Other	164			82
Total deferred tax assets	882			792
Valuation Allowance	$	(54	)	$	(9	)
Net deferred tax assets	$	828		$	783
Net deferred income taxes	$	(83	)	$	(16	)



	2018			2017
Deferred taxes included within:
Assets:
Deferred income taxes	$	152		$	188
Liabilities:
Deferred income taxes	(235		)	(204		)
Net deferred income taxes	$	(83	)	$	(16	)

Applicable U.S. income and foreign withholding taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries.

Net tax benefit of $2 in 2018, net tax benefit of $37 in 2017, and net tax benefit of $85 in 2016 were recorded directly through equity. The net tax benefit in 2018 predominantly includes current and future tax impacts related to benefit plans. The amounts in 2017 and 2016 include current and future tax impacts related to employee equity compensation and benefit plans.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.

Unrecognized tax benefits activity for the years ended December 31, 2018, 2017 and 2016 is summarized below:



	2018			2017			2016
Unrecognized tax benefits:
Balance, January 1	$	214		$	201		$	186
Increases as a result of tax positions taken during the current year	14			13			9
Decreases of tax positions taken during prior years	(37		)	(9		)	(45		)
Increases of tax positions taken during prior years	9			15			71
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(6		)	(15		)	(18		)
Effect of foreign currency rate movements	(4		)	9			(2		)
Balance, December 31	$	190		$	214		$	201

If all of the unrecognized tax benefits for 2018 above were recognized, approximately $180 would impact the effective tax rate and would result in a cash outflow of approximately $186. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next 12 months, the Company does not expect material changes.

The Company recognized approximately $1 of interest benefit and approximately $11 and $2 of interest expense related to the above unrecognized tax benefits within income tax expense in 2018, 2017 and 2016, respectively. The Company had accrued interest of approximately $27, $28 and $17 as of December 31, 2018, 2017 and 2016, respectively.

The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2011 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2011, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2013. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The Company has made an accounting policy election to treat Global Intangible Low-Taxed Income taxes as a current period expense rather than including these amounts in the measurement of deferred taxes.

Earnings Per Share

12 Months Ended

Dec. 31, 2018

Earnings Per Share [Abstract]

Earnings Per Share

For the years ended December 31, 2018, 2017 and 2016, earnings per share were as follows:



	2018					2017					2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,400	870.6	$	2.76	$	2,024	881.8	$	2.30	$	2,441	891.8	$	2.74
Stock options and restricted stock units			2.4					6.0					6.6
Diluted EPS	$	2,400	873.0	$	2.75	$	2,024	887.8	$	2.28	$	2,441	898.4	$	2.72

Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.

Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.

As of December 31, 2018, 2017 and 2016, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 18,039,961, 11,056,725 and 3,187,485, respectively. As of December 31, 2018, 2017 and 2016, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 9,529, 91 and 2,693, respectively.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Minimum rental commitments under noncancellable operating leases, primarily for office and warehouse facilities, are $193 in 2019, $165 in 2020, $123 in 2021, $102 in 2022, $51 in 2023 and $32 thereafter. Rental expense amounted to $213 in 2018, $211 in 2017 and $204 in 2016. Capital leases included in fixed assets, contingent rentals and sublease income are not significant. The Company has various contractual commitments to purchase raw, packaging and other materials totaling approximately $440 at December 31, 2018.

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $151. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful in its administrative appeals, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.

In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $65, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.

Competition Matters

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status of pending competition law matters as of December 31, 2018 is set forth below.

▪

In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is indemnified for these fines by Unilever pursuant to the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company is appealing the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court.


▪	In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company is appealing the decision to the Greek courts.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2018, there were 239 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 193 cases as of December 31, 2017. During the year ended December 31, 2018, 132 new cases were filed and 86 cases were resolved by voluntary dismissal, judgment in the Company’s favor or settlement. The value of settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. Since the amount of any potential losses from these cases currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

Segment Information

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

Effective January 1, 2018, as required, the Company adopted ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost” on a retrospective basis. To conform to the current year’s presentation, for the twelve months ended December 31, 2017 and 2016, the Company reclassified $118 and $118, respectively, of non-service related components of pension and other postretirement costs, which was previously deducted from Operating profit, to a new line item, “Non-service related postretirement costs,” which is below Operating profit. The impact of the reclassification from Operating profit by segment for the twelve months ended December 31, 2017 is as follows: North America $57, Latin America $9, Europe $6, Asia Pacific $1, Africa/Eurasia $1, Pet Nutrition $24 and Corporate $20. The impact of the reclassification from Operating profit by segment for the twelve months ended December 31, 2016 is as follows: North America $57, Latin America $7, Europe $7, Asia Pacific $1, Africa/Eurasia $1, Pet Nutrition $24 and Corporate $21. The reclassification had no effect on Net income attributable to Colgate-Palmolive Company, Earnings per common share or Cash flow.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart, Inc. and its affiliates represent approximately 11% of the Company’s Net sales in 2018. No other customer represents more than 10% of Net sales.

In 2018, 2017 and 2016, Corporate Operating profit included charges of $152, $313 and $216, respectively, resulting from the Global Growth and Efficiency Program. In 2016, Corporate Operating profit also included charges of $17 for a litigation matter and a gain of $97 on the sale of land in Mexico.



	2018		2017		2016
Net sales
Oral, Personal and Home Care
North America⁽¹⁾	$	3,348	$	3,117	$	3,183
Latin America	3,605		3,887		3,650
Europe	2,502		2,394		2,342
Asia Pacific	2,734		2,781		2,796
Africa/Eurasia	967		983		960
Total Oral, Personal and Home Care	13,156		13,162		12,931
Pet Nutrition⁽²⁾	2,388		2,292		2,264
Total Net sales	$	15,544	$	15,454	$	15,195

_________

⁽¹⁾Net sales in the U.S. for Oral, Personal and Home Care were $3,091, $2,865 and $2,932 in 2018, 2017 and 2016, respectively.

⁽²⁾Net sales in the U.S. for Pet Nutrition were $1,304, $1,246 and $1,243 in 2018, 2017 and 2016, respectively.



	2018			2017			2016
Operating profit
Oral, Personal and Home Care
North America	$	1,037		$	1,043		$	1,087
Latin America	995			1,171			1,139
Europe	634			605			586
Asia Pacific	777			842			888
Africa/Eurasia	173			180			187
Total Oral, Personal and Home Care	3,616			3,841			3,887
Pet Nutrition	680			677			677
Corporate	(602		)	(811		)	(609		)
Total Operating profit	$	3,694		$	3,707		$	3,955



	2018		2017		2016
Capital expenditures
Oral, Personal and Home Care
North America	$	53	$	74	$	151
Latin America	131		127		94
Europe	39		63		51
Asia Pacific	75		125		120
Africa/Eurasia	11		13		17
Total Oral, Personal and Home Care	309		402		433
Pet Nutrition	35		33		38
Corporate	92		118		122
Total Capital expenditures	$	436	$	553	$	593



	2018		2017		2016
Depreciation and amortization
Oral, Personal and Home Care
North America	$	88	$	58	$	54
Latin America	82		82		76
Europe	70		74		64
Asia Pacific	103		101		96
Africa/Eurasia	8		8		7
Total Oral, Personal and Home Care	351		323		297
Pet Nutrition	53		53		53
Corporate	107		99		93
Total Depreciation and amortization	$	511	$	475	$	443



	2018		2017		2016
Identifiable assets
Oral, Personal and Home Care
North America	$	3,310	$	2,608	$	2,685
Latin America	2,225		2,423		2,314
Europe	2,883		3,781		3,554
Asia Pacific	2,148		2,244		2,006
Africa/Eurasia	502		544		499
Total Oral, Personal and Home Care	11,068		11,600		11,058
Pet Nutrition	1,033		1,026		1,009
Corporate⁽¹⁾	60		50		56
Total Identifiable assets⁽²⁾	$	12,161	$	12,676	$	12,123

____________


⁽¹⁾	In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). In 2017, Corporate identifiable assets primarily consist of derivative instruments (5%) and investments in equity securities (86%). In 2016, Corporate identifiable assets primarily consist of derivative instruments (24%) and investments in equity securities (68%).


⁽²⁾	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-half of total long-lived assets of $8,259 in 2018 and one-third of total long-lived assets of $7,908 and $7,642 in 2017 and 2016, respectively.

Supplemental Income Statement Information

12 Months Ended

Dec. 31, 2018

Supplemental Income Statement Elements [Abstract]

Supplemental Income Statement Information



Other (income) expense, net	2018			2017			2016
Global Growth and Efficiency Program	$	88		$	152		$	93
Amortization of intangible assets	59			35			33
Gain on sale of land in Mexico	—			—			(97		)
Charges for a litigation matter	—			—			17
Equity income	(10		)	(11		)	(10		)
Other, net	11			(3		)	(11		)
Total Other (income) expense, net	$	148		$	173		$	25



Interest (income) expense, net	2018			2017			2016
Interest incurred	$	195		$	156		$	155
Interest capitalized	(2		)	(3		)	(6		)
Interest income	(50		)	(51		)	(50		)
Total Interest (income) expense, net	$	143		$	102		$	99



	2018		2017		2016
Research and development	$	277	$	285	$	289
Advertising	$	1,590	$	1,573	$	1,428

Supplemental Balance Sheet Information

12 Months Ended

Dec. 31, 2018

Balance Sheet Related Disclosures [Abstract]

Supplemental Balance Sheet Information

Inventories by major class are as follows at December 31:



Inventories	2018		2017
Raw materials and supplies	$	253	$	267
Work-in-process	37		42
Finished goods	960		912
Total Inventories	$	1,250	$	1,221

Inventories valued under LIFO amounted to $294 and $289 at December 31, 2018 and 2017, respectively. The excess of current cost over LIFO cost at the end of each year was $63. The liquidations of LIFO inventory quantities had no material effect on income in 2018, 2017 and 2016.



Property, plant and equipment, net	2018			2017
Land	$	152		$	159
Buildings	1,604			1,655
Manufacturing machinery and equipment	5,157			5,165
Other equipment	1,423			1,481
	8,336			8,460
Accumulated depreciation	(4,455		)	(4,388		)
Total Property, plant and equipment, net	$	3,881		$	4,072



Other accruals	2018		2017
Accrued advertising and coupon redemption	$	486	$	510
Accrued payroll and employee benefits	275		325
Accrued taxes other than income taxes	127		123
Restructuring accrual	148		181
Pension and other retiree benefits	84		81
Accrued interest	35		34
Derivatives	9		20
Other	532		557
Total Other accruals	$	1,696	$	1,831



Other liabilities	2018		2017
Pension and other retiree benefits	$	1,600	$	1,724
Restructuring accrual	54		53
Other	380		478
Total Other liabilities	$	2,034	$	2,255

Supplemental Other Comprehensive Income (Loss) Information

12 Months Ended

Dec. 31, 2018

Equity [Abstract]

Supplemental Other Comprehensive Income (Loss) Information

Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:



	2018						2017						2016
	Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax

Cumulative translation adjustments	$	(233	)	$	(218	)	$	218		$	285		$	(97	)	$	(125	)
Pension and other benefits:
Net actuarial gain (loss), prior service costs and settlements during the period	(21		)	(16		)	21			9			(231		)	(152		)
Amortization of net actuarial loss, transition and prior service costs⁽¹⁾	69			54			71			45			63			43
Retirement Plan and other retiree benefit adjustments	48			38			92			54			(168		)	(109		)
Available-for-sale securities:
Reclassification of (gains) losses into net earnings on available- for-sale securities	—			—			—			—			(1		)	(1		)
Gains (losses) on available-for-sale securities	—			—			—			—			(1		)	(1		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	10			8			(25		)	(16		)	11			8
Reclassification of (gains) losses into net earnings on cash flow hedges⁽²⁾	3			2			3			2			(4		)	(3		)
Gains (losses) on cash flow hedges	13			10			(22		)	(14		)	7			5
Total Other comprehensive income (loss)	$	(172	)	$	(170	)	$	288		$	325		$	(259	)	$	(230	)

_________


⁽¹⁾	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.


⁽²⁾	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs, unrealized gains and losses from derivative instruments designated as cash flow hedges and unrealized gains and losses on available-for-sale securities. At December 31, 2018 and 2017, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,038 and $923, respectively, and cumulative foreign currency translation adjustments of $3,155 and $2,927, respectively. Foreign currency translation adjustments in 2018 primarily reflect losses from the euro and the Argentine peso. Foreign currency translation adjustments in 2017 primarily reflect gains from the euro.

Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2018

Quarterly Financial Data [Abstract]

Quarterly Financial Data (Unaudited)



	Total			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2018
Net sales	$	15,544		$	4,002		$	3,886		$	3,845		$	3,811
Gross profit	9,231		⁽¹⁾	2,408		⁽³⁾	2,301		⁽⁵⁾	2,269		⁽⁷⁾	2,253		⁽⁹⁾
Net income including noncontrolling interests	2,558		⁽²⁾	678		⁽⁴⁾	675		⁽⁶⁾	562		⁽⁸⁾	643		⁽¹⁰⁾
Net income attributable to Colgate-Palmolive Company	2,400		⁽²⁾	634		⁽⁴⁾	637		⁽⁶⁾	523		⁽⁸⁾	606		⁽¹⁰⁾
Earnings per common share:
Basic	2.76		⁽²⁾	0.72		⁽⁴⁾	0.73		⁽⁶⁾	0.60		⁽⁸⁾	0.70		⁽¹⁰⁾
Diluted	2.75		⁽²⁾	0.72		⁽⁴⁾	0.73		⁽⁶⁾	0.60		⁽⁸⁾	0.70		⁽¹⁰⁾

2017
Net sales	$	15,454		$	3,762		$	3,826		$	3,974		$	3,892
Gross profit	9,280		⁽¹¹⁾	2,269		⁽¹³⁾	2,300		⁽¹⁵⁾	2,383		⁽¹⁷⁾	2,328		⁽¹⁹⁾
Net income including noncontrolling interests	2,174		⁽¹²⁾	611		⁽¹⁴⁾	560		⁽¹⁶⁾	650		⁽¹⁸⁾	353		⁽²⁰⁾
Net income attributable to Colgate-Palmolive Company	2,024		⁽¹²⁾	570		⁽¹⁴⁾	524		⁽¹⁶⁾	607		⁽¹⁸⁾	323		⁽²⁰⁾
Earnings per common share:
Basic	2.30		⁽¹²⁾	0.64		⁽¹⁴⁾	0.59		⁽¹⁶⁾	0.69		⁽¹⁸⁾	0.37		⁽²⁰⁾
Diluted	2.28		⁽¹²⁾	0.64		⁽¹⁴⁾	0.59		⁽¹⁶⁾	0.68		⁽¹⁸⁾	0.37		⁽²⁰⁾

____________


Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.


⁽¹⁾	Gross profit for the full year of 2018 includes $31 of charges related to the Global Growth and Efficiency Program.

⁽²⁾

Net income including noncontrolling interests for the full year of 2018 includes $124 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2018 include $125 of aftertax charges related to the Global Growth and Efficiency Program, an $80 charge related to U.S. tax reform and a $15 benefit from a foreign tax matter.


⁽³⁾	Gross profit for the first quarter of 2018 includes $6 of charges related to the Global Growth and Efficiency Program.


⁽⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2018 include $20 of aftertax charges related to the Global Growth and Efficiency Program.


⁽⁵⁾	Gross profit for the second quarter of 2018 includes $5 of charges related to the Global Growth and Efficiency Program.

⁽⁶⁾

Net income including noncontrolling interests for the second quarter of 2018 includes $48 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2018 include $51 of aftertax charges related to the Global Growth and Efficiency Program and a $15 benefit from a foreign tax matter.


⁽⁷⁾	Gross profit for the third quarter of 2018 includes $8 of charges related to the Global Growth and Efficiency Program.


⁽⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2018 include $22 of aftertax charges related to the Global Growth and Efficiency Program and an $80 charge related to U.S. tax reform.


⁽⁹⁾	Gross profit for the fourth quarter of 2018 includes $12 of charges related to the Global Growth and Efficiency Program.


⁽¹⁰⁾	Net income including noncontrolling interests for the fourth quarter of 2018 includes $34 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2018 include $32 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹¹⁾	Gross profit for the full year of 2017 includes $75 of charges related to the Global Growth and Efficiency Program.


⁽¹²⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2017 include $246 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform.


⁽¹³⁾	Gross profit for the first quarter of 2017 includes $14 of charges related to the Global Growth and Efficiency Program.


⁽¹⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2017 include $31 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁵⁾	Gross profit for the second quarter of 2017 includes $21 of charges related to the Global Growth and Efficiency Program.


⁽¹⁶⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2017 include $115 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁷⁾	Gross profit for the third quarter of 2017 includes $16 of charges related to the Global Growth and Efficiency Program.


⁽¹⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2017 include $39 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁹⁾	Gross profit for the fourth quarter of 2017 includes $24 of charges related to the Global Growth and Efficiency Program.


⁽²⁰⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2017 include $61 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform.

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2018

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

COLGATE-PALMOLIVE COMPANY

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

(Dollars in Millions)




			Additions
	Balance at Beginning of Period		Charged to Costs and Expenses		Other		Deductions		Balance at End of Period
Year Ended December 31, 2018
Allowance for doubtful accounts and estimated returns	$	77	$	15	$	—	$	10	$	82
Valuation allowance for deferred tax assets	$	9	$	45	$	—	$	—	$	54

Year Ended December 31, 2017
Allowance for doubtful accounts and estimated returns	$	73	$	8	$	—	$	4	$	77
Valuation allowance for deferred tax assets	$	—	$	9	$	—	$	—	$	9

Year Ended December 31, 2016
Allowance for doubtful accounts and estimated returns	$	59	$	18	$	—	$	4	$	73
Valuation allowance for deferred tax assets	$	—	$	—	$	—	$	—	$	—

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2018
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2018 and 2017, equity method investments included in Other assets in the Consolidated Balance Sheets were $46 and $42, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves and charges related to U.S. tax reform (see Note 11, Income Taxes). Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	Revenue Recognition The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to direct the “use of” and “obtain” the benefit from our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,255, $1,183 and $1,140 for the years ended December 31, 2018, 2017 and 2016, respectively.
Marketing Costs	Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories	Inventories The cost of approximately 75% of inventories is determined using the first-in, first-out (“FIFO”) method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method, which is stated at the lower of cost or market.
Property, Plant and Equipment	Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
Financial Instruments	Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to estimate the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
Currency Translation	Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-15, “Intangibles–Goodwill and Other–Internal–Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis and does not expect the guidance to have a material impact on the Company’s Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-14, “Compensation–Retirement Benefits–Defined Benefit Plans–General (Topic 715): Disclosure Framework–Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning in the year ending December 31, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In February 2018, the FASB issued ASU No. 2018-02, “Income Statement–Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”), which permits the reclassification of stranded tax effects resulting from the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) from Accumulated other comprehensive income (loss) to Retained earnings. This new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted, and must be applied either in the period of adoption or retrospectively to periods in which the effects of the TCJA are recognized. The Company elected to adopt this new guidance early, beginning on January 1, 2018, and reclassified $163 during the first quarter of 2018. In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. In October 2018, the FASB issued ASU No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance is effective for the Company beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12, with early adoption permitted. The new guidance is required to be applied on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements. In May 2017, the FASB issued ASU No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a stock-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2018 and did not impact the Company’s Consolidated Financial Statements, as it is not the Company’s practice to change either the terms or the conditions of stock-based payment awards once they are granted. In March 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. The non-service related components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement was adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization was adopted on a prospective basis. Effective January 1, 2018, as required, the Company adopted this standard on a retrospective basis. As permitted by the new guidance, the Company used the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the basis for applying the retrospective presentation requirements. As a result, for all periods presented, only the service related component of pension and other postretirement benefit costs is included in Operating profit. For the years ended December 31, 2017 and 2016, the Company reclassified $118 and $118, respectively, of non-service related components of pension and other postretirement costs, which was previously deducted from Operating profit, to a new line item, “Non-service related postretirement costs,” which is below Operating profit. Adoption of this standard had no effect on Net income attributable to Colgate-Palmolive Company, Earnings per common share or Cash flow. In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements. In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance did not have an impact on the Company’s Consolidated Financial Statements. In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance was effective for the Company on January 1, 2018. This new guidance did not have an impact on the Company’s Consolidated Financial Statements. In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases.” The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, and enhanced disclosures about the Company’s leasing arrangements. Substantially all of the Company’s leases are considered operating leases and, as such, under accounting standards in effect at December 31, 2018, were not recognized on the Company’s Consolidated Balance Sheets as of December 31, 2018 and 2017. In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” to clarify the implementation guidance and ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements.” This updated guidance provided an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. The Company adopted the new standard beginning on January 1, 2019 and elected the optional transition method with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard is expected to result in the recognition of right-of-use assets of approximately $450 and liabilities of approximately $575, with no material cumulative effect adjustment to its Consolidated Balance Sheet as of the date of adoption. Adoption of the new standard will not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments, which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard was effective for the Company beginning on January 1, 2018 and did not have an impact on the Company’s Consolidated Financial Statements. In May 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company adopted the new standard on January 1, 2018, on a “modified retrospective” basis, which did not have a material impact on the Company’s Consolidated Financial Statements. As required, the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the 2018 opening balance of retained earnings. Results for periods beginning on or after January 1, 2018 are presented under Topic 606, “Revenue from Contracts with Customers,” while prior period amounts are not adjusted and continue to be reported in accordance with the prior accounting guidance under Topic 605, “Revenue Recognition.”
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Nature of Operations (Tables)

12 Months Ended

Dec. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Percentage of worldwide sales

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:



	2018		2017		2016
Oral Care	47	%	48	%	47	%
Personal Care	20	%	19	%	20	%
Home Care	18	%	18	%	18	%
Pet Nutrition	15	%	15	%	15	%
Total	100	%	100	%	100	%

Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2018

Business Combinations [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Total purchase price consideration of $730 has been allocated to the net assets acquired based on their respective estimated fair values as follows:



Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	8
Other current assets	8
Other intangible assets	369
Goodwill	397
Other current liabilities	(6		)
Deferred income taxes	(46		)
Fair value of net assets acquired	$	730

Restructuring and Related Implementation Charges (Tables)

12 Months Ended

Dec. 31, 2018

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the years ended December 31, 2018, 2017 and 2016, restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows:



	2018		2017		2016
Cost of sales	$	31	$	75	$	46
Selling, general and administrative expenses	33		86		77
Other (income) expense, net	88		152		93
Non-service related postretirement costs	9		20		12
Total Global Growth and Efficiency Program charges, pretax	$	161	$	333	$	228

Total Global Growth and Efficiency Program charges, aftertax	$	125	$	246	$	168

Schedule of Percent of Total Restructuring Charges Related To Segment for the period

Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:



							Program-to-date
	2018		2017		2016		Accumulated Charges
North America	18	%	23	%	35	%	18	%
Latin America	10	%	2	%	5	%	4	%
Europe	(2	)%	21	%	12	%	20	%
Asia Pacific	13	%	5	%	4	%	4	%
Africa/Eurasia	5	%	3	%	14	%	6	%
Hill’s Pet Nutrition	19	%	6	%	7	%	8	%
Corporate	37	%	40	%	23	%	40	%
Total	100	%	100	%	100	%	100	%

Schedule of Restructuring and Related Costs Incurred to Date



	Cumulative Charges
	as of December 31, 2018
Employee-Related Costs	$	681
Incremental Depreciation	92
Asset Impairments	52
Other	897
Total	$	1,722

Schedule of Restructuring Reserve by Type of Cost

The following table summarizes the activity for the restructuring and related implementation charges, in the respective periods, discussed above and the related accruals:



	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at January 1, 2016	$	84		$	—		$	—		$	131		$	215
Charges	61			9			20			138			228
Cash payments	(84		)	—			—			(153		)	(237		)
Charges against assets	(4		)	(9		)	(20		)	—			(33		)
Foreign exchange	(1		)	—			—			—			(1		)
Other	—			—			—			9			9
Balance at December 31, 2016	$	56		$	—		$	—		$	125		$	181
Charges	163			10			9			151			333
Cash payments	(74		)	—			—			(170		)	(244		)
Charges against assets	(21		)	(10		)	(9		)	—			(40		)
Foreign exchange	3			—			—			1			4
Other	—			—			—			—			—
Balance at December 31, 2017	$	127		$	—		$	—		$	107		$	234
Charges	53			2			16			90			161
Cash payments	(107		)	—			—			(60		)	(167		)
Charges against assets	(9		)	(2		)	(16		)	—			(27		)
Foreign exchange	(4		)	—			—			—			(4		)
Other	—			—			—			5			5
Balance at December 31, 2018	$	60		$	—		$	—		$	142		$	202

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The net carrying value of Goodwill as of December 31, 2018 and 2017 by segment was as follows:



	2018		2017
Oral, Personal and Home Care
North America	$	733	$	343
Latin America	220		256
Europe	1,302		1,333
Asia Pacific	185		190
Africa/Eurasia	75		81
Total Oral, Personal and Home Care	2,515		2,203
Pet Nutrition	15		15
Total Goodwill	$	2,530	$	2,218

Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class

Other intangible assets as of December 31, 2018 and 2017 were comprised of the following:



	2018							2017
	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Trademarks	$	771	$	(358	)	$	413	$	547	$	(337	)	$	210
Other finite life intangible assets	390		(133		)	257		249		(103		)	146
Indefinite life intangible assets	967		—			967		985		—			985
Total Other intangible assets	$	2,128	$	(491	)	$	1,637	$	1,781	$	(440	)	$	1,341

Long-Term Debt and Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt consisted of the following at December 31:



	Weighted Average Interest Rate	Maturities			2018		2017
Notes	2.8%	2019	-	2078	$	5,820	$	6,542
Commercial paper	2.5%	2019			534		24
					6,354		6,566
Less: Current portion of long-term debt					—		—
Total					$	6,354	$	6,566

Schedule of Maturities of Long-term Debt

Excluding such obligations, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2018, were as follows:



Years Ended December 31,
2019	$	—
2020	249
2021	298
2022	886
2023	893
Thereafter	2,422

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Schedule of Derivative Instruments

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2018 and December 31, 2017:



	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		12/31/18		12/31/17			12/31/18		12/31/17
Interest rate swap contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	—
Interest rate swap contracts	Other assets	—		—		Other liabilities	8		7
Foreign currency contracts	Other current assets	20		25		Other accruals	8		20
Foreign currency contracts	Other assets	—		—		Other liabilities	21		46
Commodity contracts	Other current assets	—		—		Other accruals	—		—
Total designated		$	20	$	25		$	38	$	73

Other financial instruments
Marketable securities	Other current assets	$	10	$	14
Total other financial instruments		$	10	$	14

Activity related to fair value hedges

Activity related to fair value hedges recorded during each period presented was as follows:



	2018									2017
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at December 31,	$	327		$	900		$	1,227		$	1,231		$	1,000		$	2,231
Gain (loss) on derivatives	(1		)	(2		)	(3		)	(7		)	(9		)	(16		)
Gain (loss) on hedged items	1			2			3			7			9			16

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during each period presented was as follows:



	2018								2017
	Foreign Currency Contracts			Commodity Contracts		Total			Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at December 31,	$	782		$	14	$	796		$	702		$	—	$	702
Gain (loss) recognized in OCI	10			—		10			(25		)	—		(25		)
Gain (loss) reclassified into Cost of sales	(4		)	1		(3		)	(3		)	—		(3		)

Activity related to net investment hedges recorded during each period presented was as follows:



	2018									2017
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at December 31,	$	482		$	1,396		$	1,878		$	478		$	601		$	1,079
Gain (loss) on instruments	33			93			126			(71		)	(112		)	(183		)
Gain (loss) on hedged items	(33		)	(93		)	(126		)	71			112			183

Capital Stock and Stock-Based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule Of Common And Treasury Stock Activity

A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:



	Common Stock Outstanding		Treasury Stock
Balance, January 1, 2016	892,738,518		572,967,842

Common stock acquired	(19,271,304	)	19,271,304
Shares issued for stock options	8,536,639		(8,536,639	)
Shares issued for restricted stock units and other	1,105,110		(1,105,110	)
Balance, December 31, 2016	883,108,963		582,597,397

Common stock acquired	(19,185,828	)	19,185,828
Shares issued for stock options	9,670,988		(9,670,988	)
Shares issued for restricted stock units and other	1,106,995		(1,106,995	)
Balance, December 31, 2017	874,701,118		591,005,242

Common stock acquired	(18,786,897	)	18,786,897
Shares issued for stock options	6,040,920		(6,040,920	)
Shares issued for restricted stock units and other	957,651		(957,651	)
Balance, December 31, 2018	862,912,792		602,793,568

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:



	2018		2017		2016
Expected term of options	4.5 years		4.5 years		4.5 years
Expected volatility rate	17.7	%	16.0	%	16.7	%
Risk-free interest rate	2.8	%	1.8	%	1.2	%
Expected dividend yield	2.5	%	2.2	%	2.1	%

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of restricted stock unit activity during 2018 is presented below:



	Shares (in thousands)		Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 2018	2,730		$	70
Activity:
Granted	814		69
Vested	(901	)	65
Forfeited	(169	)	70
Restricted stock units as of December 31, 2018	2,474		$	71

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity during 2018 is presented below:



	Shares (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Intrinsic Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2018	40,979		$	65
Granted	6,290		68
Exercised	(6,669	)	55
Forfeited or expired	(890	)	71
Options outstanding, December 31, 2018	39,710		67		3	$	1,457
Options exercisable, December 31, 2018	26,420		$	66	3	$	1,457

Retirement Plans and Other Retiree Benefits (Tables)

12 Months Ended

Dec. 31, 2018

Retirement Benefits [Abstract]

Schedule of Allocation of Plan Assets

The target asset allocation for the Company’s defined benefit plans is as follows:



	United States		International
Asset Category
Equity securities	22	%	37	%
Fixed income securities	60	%	43	%
Real estate and other investments	18	%	20	%
Total	100	%	100	%

At December 31, 2018 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States			International		Other Retiree Benefit Plans

Cash and cash equivalents	Level 1	$	29		$	9	$	1
U.S. common stocks	Level 1	75			3		3
International common stocks	Level 1	—			4		—
Pooled funds⁽¹⁾	Level 1	106			82		4
Fixed income securities⁽²⁾	Level 2	865			24		28
Guaranteed investment contracts⁽³⁾	Level 2	1			51		—
		1,076			173		36
Investments valued using NAV per share⁽⁴⁾
Domestic, developed and emerging markets equity funds		229			134		8
Fixed income funds⁽⁵⁾		116			173		4
Hedge funds⁽⁶⁾		56			6		2
Multi-Asset funds⁽⁷⁾		94			2		3
Real estate funds⁽⁸⁾		39			22		1
		534			337		18

Other assets and liabilities, net⁽⁹⁾		(42		)	—		—
Total Investments		$	1,568		$	510	$	54

At December 31, 2017 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:



	Level of Valuation Input	Pension Plans
	Level of Valuation Input	United States			International		Other Retiree Benefit Plans

Cash and cash equivalents	Level 1	$	21		$	11	$	—
U.S. common stocks	Level 1	127			4		—
International common stocks	Level 1	—			3		—
Pooled funds⁽¹⁾	Level 1	138			94		—
Fixed income securities⁽²⁾	Level 2	843			24		—
Guaranteed investment contracts⁽³⁾	Level 2	1			53		—
		1,130			189		—
Investments valued using NAV per share⁽⁴⁾
Domestic, developed and emerging markets equity funds		350			189		—
Fixed income funds⁽⁵⁾		122			167		—
Hedge funds⁽⁶⁾		82			5		—
Multi-Asset funds⁽⁷⁾		115			3		—
Real estate funds⁽⁸⁾		38			22		—
		707			386		—

Other assets and liabilities, net⁽⁹⁾		(25		)	—		—
Total Investments		$	1,812		$	575	$	—

_______


⁽¹⁾	Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.


⁽²⁾	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of both December 31, 2018 and 2017, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.


⁽³⁾	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.

⁽⁴⁾


⁽⁵⁾	Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.


⁽⁶⁾	Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.


⁽⁷⁾	Multi-Asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.


⁽⁸⁾	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.


⁽⁹⁾	This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.

Defined benefit plans disclosures



	Pension Plans												Other Retiree Benefit Plans
	2018			2017			2018			2017			2018			2017
	United States						International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	2,363		$	2,298		$	847		$	800		$	960		$	923
Service cost	1			1			14			16			16			13
Interest cost	86			94			21			22			38			40
Participants’ contributions	—			—			2			2			—			—
Acquisitions/plan amendments	—			—			4			(6		)	—			—
Actuarial loss (gain)	(139		)	110			(11		)	(11		)	(88		)	21
Foreign exchange impact	—			—			(40		)	72			(5		)	3
Termination benefits⁽¹⁾	9			24			—			—			—			(3		)
Curtailments and settlements	(4		)	—			(7		)	(11		)	—			—
Benefit payments	(169		)	(164		)	(42		)	(36		)	(45		)	(37		)
Other	—			—			(1		)	(1		)	—			—
Benefit obligations at end of year	$	2,147		$	2,363		$	787		$	847		$	876		$	960
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,812		$	1,646		$	575		$	509		$	—		$	—
Actual return on plan assets	(101		)	225			(16		)	42			(1		)	—
Company contributions	30			105			27			30			100			37
Participants’ contributions	—			—			3			2			—			—
Foreign exchange impact	—			—			(29		)	40			—			—
Settlements and acquisitions	(4		)	—			(7		)	(11		)	—			—
Benefit payments	(169		)	(164		)	(42		)	(36		)	(45		)	(37		)
Other	—			—			(1		)	(1		)	—			—
Fair value of plan assets at end of year	$	1,568		$	1,812		$	510		$	575		$	54		$	—
Funded Status
Benefit obligations at end of year	$	2,147		$	2,363		$	787		$	847		$	876		$	960
Fair value of plan assets at end of year	1,568			1,812			510			575			54			—
Net amount recognized	$	(579	)	$	(551	)	$	(277	)	$	(272	)	$	(822	)	$	(960	)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	—		$	—		$	6		$	22		$	—		$	—
Current liabilities	(26		)	(24		)	(12		)	(13		)	(46		)	(44		)
Noncurrent liabilities	(553		)	(527		)	(271		)	(281		)	(776		)	(916		)
Net amount recognized	$	(579	)	$	(551	)	$	(277	)	$	(272	)	$	(822	)	$	(960	)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	$	940		$	911		$	226		$	209		$	239		$	338
Transition/prior service cost	1			1			6			1			(1		)	(1		)
	$	941		$	912		$	232		$	210		$	238		$	337
Accumulated benefit obligation	$	2,090		$	2,293		$	731		$	787		$	—		$	—



	Pension Plans								Other Retiree Benefit Plans
	2018		2017		2018		2017		2018		2017
	United States				International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.38	%	3.73	%	2.80	%	2.53	%	4.43	%	3.80	%
Long-term rate of return on plan assets	6.60	%	6.60	%	4.06	%	4.04	%	6.60	%	6.60	%
Long-term rate of compensation increase	3.50	%	3.50	%	2.86	%	2.79	%	3.50	%	3.50	%
ESOP growth rate	—	%	—	%	—	%	—	%	10.00	%	10.00	%
Medical cost trend rate of increase	—	%	—	%	—	%	—	%	6.00	%	6.00	%

_________


⁽¹⁾	Represents pension and other retiree benefit enhancements incurred in 2018 and 2017 pursuant to the Global Growth and Efficiency Program.

Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates

A 1% change in the assumed medical cost trend rate would have the following approximate effect:



	One percentage point
	Increase		Decrease
Accumulated postretirement benefit obligation	$	115	$	(93	)
Total of service and interest cost components	10		(7		)

Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets

Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:



	Years Ended December 31,
	2018		2017
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	2,882	$	2,834
Fair value of plan assets	2,007		1,992

Accumulated benefit obligation	2,689		2,641
Fair value of plan assets	1,924		1,905

Schedule of Net Benefit Costs

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:



	Pension Plans																		Other Retiree Benefit Plans
	2018			2017			2016			2018			2017			2016			2018			2017			2016
	United States									International
Components of Net Periodic Benefit Cost
Service cost	$	1		$	1		$	1		$	14		$	16		$	16		$	16		$	13		$	13
Interest cost	86			94			105			21			22			25			38			40			43
Annual ESOP allocation	—			—			—			—			—			—			—			—			—
Expected return on plan assets	(115		)	(111		)	(109		)	(21		)	(22		)	(23		)	(2		)	—			(1		)
Amortization of transition and prior service costs (credits)	—			—			—			—			—			—			—			—			—
Amortization of actuarial loss	47			48			41			8			10			8			14			13			14
Net periodic benefit cost	$	19		$	32		$	38		$	22		$	26		$	26		$	66		$	66		$	69
Other postretirement charges	9			24			3			2			4			11			—			(3		)	1
Total pension cost	$	28		$	56		$	41		$	24		$	30		$	37		$	66		$	63		$	70
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	3.73		%	4.27		%	4.93		%	2.53		%	2.59		%	3.17		%	3.80		%	4.41		%	4.97		%
Long-term rate of return on plan assets	6.60		%	6.80		%	6.80		%	4.04		%	4.14		%	4.62		%	6.60		%	6.80		%	6.80		%
Long-term rate of compensation increase	3.50		%	3.50		%	3.50		%	2.79		%	2.58		%	2.78		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%	—		%	—		%	—		%	10.00		%	10.00		%	10.00		%
Medical cost trend rate of increase	—		%	—		%	—		%	—		%	—		%	—		%	6.00		%	6.33		%	6.67		%

Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year



	Pension Plans		Other Retiree Benefit Plans
Net actuarial loss	$	60	$	11
Net transition and prior service cost	—		—

Schedule of Expected Benefit Payments

Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows:



	Pension Plans
Years Ended December 31,	United States		International		Other Retiree Benefit Plans		Total
2019	$	149	$	35	$	47	$	231
2020	146		35		47		228
2021	147		37		48		232
2022	151		36		48		235
2023	151		40		49		240
2024-2028	736		217		256		1,209

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Components of income before income taxes

The components of Income before income taxes are as follows for the years ended December 31:



	2018		2017		2016
United States	$	1,175	$	1,072	$	1,191
International	2,289		2,415		2,547
Total Income before income taxes	$	3,464	$	3,487	$	3,738

Provision for income taxes

The Provision for income taxes consists of the following for the years ended December 31:



	2018		2017		2016
United States	$	248	$	338	$	395
International	658		975		757
Total Provision for income taxes	$	906	$	1,313	$	1,152

Schedule of components of deferred income tax benefit



	2018			2017			2016
Goodwill and intangible assets	$	2		$	135		$	18
Property, plant and equipment	(15		)	84			(3		)
Pension and other retiree benefits	(7		)	(192		)	—
Stock-based compensation	9			(28		)	15
Tax credits and tax loss carryforwards	(4		)	(4		)	5
Deferred withholding tax	(100		)	(119		)	—
Other, net	62			16			(106		)
Total deferred tax benefit (provision)	$	(53	)	$	(108	)	$	(71	)

Effective tax rate reconciliation

The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:



Percentage of Income before income taxes	2018		2017		2016
Tax at United States statutory rate	21.0	%	35.0	%	35.0	%
State income taxes, net of federal benefit	1.0		0.5		0.5
Earnings taxed at other than United States statutory rate	4.5		(3.4	)	(2.7	)
Charge for U.S. tax reform⁽¹⁾	2.3		7.9		—
Excess tax benefits from stock-based compensation⁽²⁾	(0.3	)	(1.4	)	—
Foreign Tax Credit Carryback⁽⁵⁾	(1.7	)	—		—
(Benefit) charge for foreign tax matters⁽³⁾	(0.4	)	—		(0.8	)
(Benefit) from Venezuela remeasurement⁽⁴⁾	—		—		(5.6	)
Tax charge on incremental repatriation of foreign earnings⁽⁴⁾	—		—		5.6
Other, net	(0.2	)	(0.9	)	(1.2	)
Effective tax rate	26.2	%	37.7	%	30.8	%

_________

⁽¹⁾

⁽²⁾


⁽³⁾	The benefit from a tax matter in 2016 relates to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions.

⁽⁴⁾


⁽⁵⁾	In 2018, the Company generated excess foreign taxes associated with its foreign branch operations which are being carried back to 2017. This item is not expected to be recurring.

Components of deferred tax assets (liabilities)

The components of deferred tax assets (liabilities) are as follows at December 31:



	2018			2017
Deferred tax liabilities:
Goodwill and intangible assets	$	(344	)	$	(311	)
Property, plant and equipment	(311		)	(306		)
Deferred withholding tax	(181		)	(119		)
Other	(75		)	(63		)
Total deferred tax liabilities	(911		)	(799		)
Deferred tax assets:
Pension and other retiree benefits	354			375
Tax credits and tax loss carryforwards	89			48
Accrued liabilities	180			197
Stock-based compensation	95			90
Other	164			82
Total deferred tax assets	882			792
Valuation Allowance	$	(54	)	$	(9	)
Net deferred tax assets	$	828		$	783
Net deferred income taxes	$	(83	)	$	(16	)



	2018			2017
Deferred taxes included within:
Assets:
Deferred income taxes	$	152		$	188
Liabilities:
Deferred income taxes	(235		)	(204		)
Net deferred income taxes	$	(83	)	$	(16	)

Unrecognized tax benefits activity

Unrecognized tax benefits activity for the years ended December 31, 2018, 2017 and 2016 is summarized below:



	2018			2017			2016
Unrecognized tax benefits:
Balance, January 1	$	214		$	201		$	186
Increases as a result of tax positions taken during the current year	14			13			9
Decreases of tax positions taken during prior years	(37		)	(9		)	(45		)
Increases of tax positions taken during prior years	9			15			71
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(6		)	(15		)	(18		)
Effect of foreign currency rate movements	(4		)	9			(2		)
Balance, December 31	$	190		$	214		$	201

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2018

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

For the years ended December 31, 2018, 2017 and 2016, earnings per share were as follows:



	2018					2017					2016
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,400	870.6	$	2.76	$	2,024	881.8	$	2.30	$	2,441	891.8	$	2.74
Stock options and restricted stock units			2.4					6.0					6.6
Diluted EPS	$	2,400	873.0	$	2.75	$	2,024	887.8	$	2.28	$	2,441	898.4	$	2.72

Segment Information (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Net Sales and Operating Profit by Segment



	2018		2017		2016
Net sales
Oral, Personal and Home Care
North America⁽¹⁾	$	3,348	$	3,117	$	3,183
Latin America	3,605		3,887		3,650
Europe	2,502		2,394		2,342
Asia Pacific	2,734		2,781		2,796
Africa/Eurasia	967		983		960
Total Oral, Personal and Home Care	13,156		13,162		12,931
Pet Nutrition⁽²⁾	2,388		2,292		2,264
Total Net sales	$	15,544	$	15,454	$	15,195

_________

⁽¹⁾Net sales in the U.S. for Oral, Personal and Home Care were $3,091, $2,865 and $2,932 in 2018, 2017 and 2016, respectively.

⁽²⁾Net sales in the U.S. for Pet Nutrition were $1,304, $1,246 and $1,243 in 2018, 2017 and 2016, respectively.



	2018			2017			2016
Operating profit
Oral, Personal and Home Care
North America	$	1,037		$	1,043		$	1,087
Latin America	995			1,171			1,139
Europe	634			605			586
Asia Pacific	777			842			888
Africa/Eurasia	173			180			187
Total Oral, Personal and Home Care	3,616			3,841			3,887
Pet Nutrition	680			677			677
Corporate	(602		)	(811		)	(609		)
Total Operating profit	$	3,694		$	3,707		$	3,955



	2018		2017		2016
Capital expenditures
Oral, Personal and Home Care
North America	$	53	$	74	$	151
Latin America	131		127		94
Europe	39		63		51
Asia Pacific	75		125		120
Africa/Eurasia	11		13		17
Total Oral, Personal and Home Care	309		402		433
Pet Nutrition	35		33		38
Corporate	92		118		122
Total Capital expenditures	$	436	$	553	$	593



	2018		2017		2016
Depreciation and amortization
Oral, Personal and Home Care
North America	$	88	$	58	$	54
Latin America	82		82		76
Europe	70		74		64
Asia Pacific	103		101		96
Africa/Eurasia	8		8		7
Total Oral, Personal and Home Care	351		323		297
Pet Nutrition	53		53		53
Corporate	107		99		93
Total Depreciation and amortization	$	511	$	475	$	443



	2018		2017		2016
Identifiable assets
Oral, Personal and Home Care
North America	$	3,310	$	2,608	$	2,685
Latin America	2,225		2,423		2,314
Europe	2,883		3,781		3,554
Asia Pacific	2,148		2,244		2,006
Africa/Eurasia	502		544		499
Total Oral, Personal and Home Care	11,068		11,600		11,058
Pet Nutrition	1,033		1,026		1,009
Corporate⁽¹⁾	60		50		56
Total Identifiable assets⁽²⁾	$	12,161	$	12,676	$	12,123

____________


⁽¹⁾	In 2018, Corporate identifiable assets primarily consist of derivative instruments (7%) and investments in equity securities (88%). In 2017, Corporate identifiable assets primarily consist of derivative instruments (5%) and investments in equity securities (86%). In 2016, Corporate identifiable assets primarily consist of derivative instruments (24%) and investments in equity securities (68%).


⁽²⁾	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-half of total long-lived assets of $8,259 in 2018 and one-third of total long-lived assets of $7,908 and $7,642 in 2017 and 2016, respectively.

Supplemental Income Statement Information (Tables)

12 Months Ended

Dec. 31, 2018

Supplemental Income Statement Elements [Abstract]

Other (income) expense, net



Other (income) expense, net	2018			2017			2016
Global Growth and Efficiency Program	$	88		$	152		$	93
Amortization of intangible assets	59			35			33
Gain on sale of land in Mexico	—			—			(97		)
Charges for a litigation matter	—			—			17
Equity income	(10		)	(11		)	(10		)
Other, net	11			(3		)	(11		)
Total Other (income) expense, net	$	148		$	173		$	25

Interest expense, net



Interest (income) expense, net	2018			2017			2016
Interest incurred	$	195		$	156		$	155
Interest capitalized	(2		)	(3		)	(6		)
Interest income	(50		)	(51		)	(50		)
Total Interest (income) expense, net	$	143		$	102		$	99

Research and development and Advertising



	2018		2017		2016
Research and development	$	277	$	285	$	289
Advertising	$	1,590	$	1,573	$	1,428

Supplemental Balance Sheet Information (Tables)

12 Months Ended

Dec. 31, 2018

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory, Current

Inventories by major class are as follows at December 31:



Inventories	2018		2017
Raw materials and supplies	$	253	$	267
Work-in-process	37		42
Finished goods	960		912
Total Inventories	$	1,250	$	1,221

Property, Plant and Equipment



Property, plant and equipment, net	2018			2017
Land	$	152		$	159
Buildings	1,604			1,655
Manufacturing machinery and equipment	5,157			5,165
Other equipment	1,423			1,481
	8,336			8,460
Accumulated depreciation	(4,455		)	(4,388		)
Total Property, plant and equipment, net	$	3,881		$	4,072

Other accruals



Other accruals	2018		2017
Accrued advertising and coupon redemption	$	486	$	510
Accrued payroll and employee benefits	275		325
Accrued taxes other than income taxes	127		123
Restructuring accrual	148		181
Pension and other retiree benefits	84		81
Accrued interest	35		34
Derivatives	9		20
Other	532		557
Total Other accruals	$	1,696	$	1,831

Other liabilities



Other liabilities	2018		2017
Pension and other retiree benefits	$	1,600	$	1,724
Restructuring accrual	54		53
Other	380		478
Total Other liabilities	$	2,034	$	2,255

Supplemental Other Comprehensive Income (Loss) Information (Tables)

12 Months Ended

Dec. 31, 2018

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:



	2018						2017						2016
	Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax

Cumulative translation adjustments	$	(233	)	$	(218	)	$	218		$	285		$	(97	)	$	(125	)
Pension and other benefits:
Net actuarial gain (loss), prior service costs and settlements during the period	(21		)	(16		)	21			9			(231		)	(152		)
Amortization of net actuarial loss, transition and prior service costs⁽¹⁾	69			54			71			45			63			43
Retirement Plan and other retiree benefit adjustments	48			38			92			54			(168		)	(109		)
Available-for-sale securities:
Reclassification of (gains) losses into net earnings on available- for-sale securities	—			—			—			—			(1		)	(1		)
Gains (losses) on available-for-sale securities	—			—			—			—			(1		)	(1		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	10			8			(25		)	(16		)	11			8
Reclassification of (gains) losses into net earnings on cash flow hedges⁽²⁾	3			2			3			2			(4		)	(3		)
Gains (losses) on cash flow hedges	13			10			(22		)	(14		)	7			5
Total Other comprehensive income (loss)	$	(172	)	$	(170	)	$	288		$	325		$	(259	)	$	(230	)

_________


⁽¹⁾	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.


⁽²⁾	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2018

Quarterly Financial Data [Abstract]

Schedule of Quarterly Financial Information



	Total			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2018
Net sales	$	15,544		$	4,002		$	3,886		$	3,845		$	3,811
Gross profit	9,231		⁽¹⁾	2,408		⁽³⁾	2,301		⁽⁵⁾	2,269		⁽⁷⁾	2,253		⁽⁹⁾
Net income including noncontrolling interests	2,558		⁽²⁾	678		⁽⁴⁾	675		⁽⁶⁾	562		⁽⁸⁾	643		⁽¹⁰⁾
Net income attributable to Colgate-Palmolive Company	2,400		⁽²⁾	634		⁽⁴⁾	637		⁽⁶⁾	523		⁽⁸⁾	606		⁽¹⁰⁾
Earnings per common share:
Basic	2.76		⁽²⁾	0.72		⁽⁴⁾	0.73		⁽⁶⁾	0.60		⁽⁸⁾	0.70		⁽¹⁰⁾
Diluted	2.75		⁽²⁾	0.72		⁽⁴⁾	0.73		⁽⁶⁾	0.60		⁽⁸⁾	0.70		⁽¹⁰⁾

2017
Net sales	$	15,454		$	3,762		$	3,826		$	3,974		$	3,892
Gross profit	9,280		⁽¹¹⁾	2,269		⁽¹³⁾	2,300		⁽¹⁵⁾	2,383		⁽¹⁷⁾	2,328		⁽¹⁹⁾
Net income including noncontrolling interests	2,174		⁽¹²⁾	611		⁽¹⁴⁾	560		⁽¹⁶⁾	650		⁽¹⁸⁾	353		⁽²⁰⁾
Net income attributable to Colgate-Palmolive Company	2,024		⁽¹²⁾	570		⁽¹⁴⁾	524		⁽¹⁶⁾	607		⁽¹⁸⁾	323		⁽²⁰⁾
Earnings per common share:
Basic	2.30		⁽¹²⁾	0.64		⁽¹⁴⁾	0.59		⁽¹⁶⁾	0.69		⁽¹⁸⁾	0.37		⁽²⁰⁾
Diluted	2.28		⁽¹²⁾	0.64		⁽¹⁴⁾	0.59		⁽¹⁶⁾	0.68		⁽¹⁸⁾	0.37		⁽²⁰⁾

____________


Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.


⁽¹⁾	Gross profit for the full year of 2018 includes $31 of charges related to the Global Growth and Efficiency Program.

⁽²⁾


⁽³⁾	Gross profit for the first quarter of 2018 includes $6 of charges related to the Global Growth and Efficiency Program.


⁽⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2018 include $20 of aftertax charges related to the Global Growth and Efficiency Program.


⁽⁵⁾	Gross profit for the second quarter of 2018 includes $5 of charges related to the Global Growth and Efficiency Program.

⁽⁶⁾


⁽⁷⁾	Gross profit for the third quarter of 2018 includes $8 of charges related to the Global Growth and Efficiency Program.


⁽⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2018 include $22 of aftertax charges related to the Global Growth and Efficiency Program and an $80 charge related to U.S. tax reform.


⁽⁹⁾	Gross profit for the fourth quarter of 2018 includes $12 of charges related to the Global Growth and Efficiency Program.


⁽¹⁰⁾	Net income including noncontrolling interests for the fourth quarter of 2018 includes $34 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2018 include $32 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹¹⁾	Gross profit for the full year of 2017 includes $75 of charges related to the Global Growth and Efficiency Program.


⁽¹²⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2017 include $246 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform.


⁽¹³⁾	Gross profit for the first quarter of 2017 includes $14 of charges related to the Global Growth and Efficiency Program.


⁽¹⁴⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2017 include $31 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁵⁾	Gross profit for the second quarter of 2017 includes $21 of charges related to the Global Growth and Efficiency Program.


⁽¹⁶⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2017 include $115 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁷⁾	Gross profit for the third quarter of 2017 includes $16 of charges related to the Global Growth and Efficiency Program.


⁽¹⁸⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2017 include $39 of aftertax charges related to the Global Growth and Efficiency Program.


⁽¹⁹⁾	Gross profit for the fourth quarter of 2017 includes $24 of charges related to the Global Growth and Efficiency Program.


⁽²⁰⁾	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2017 include $61 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform.

Nature of Operations (Details) - business_segment	12 Months Ended
Nature of Operations (Details) - business_segment	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of product segments (in segments)	2
Sales Revenue, Net
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	11.00%
Sales Revenue, Net \| Product Concentration Risk
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	100.00%	100.00%	100.00%
Sales Revenue, Net \| Product Concentration Risk \| Oral Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	47.00%	48.00%	47.00%
Sales Revenue, Net \| Product Concentration Risk \| Personal Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	20.00%	19.00%	20.00%
Sales Revenue, Net \| Product Concentration Risk \| Home Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	18.00%	18.00%	18.00%
Sales Revenue, Net \| Product Concentration Risk \| Pet Nutrition
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	15.00%	15.00%	15.00%

Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Principles of Consolidation [Abstract]
Investments accounted for using the equity method, minimum interest	20.00%
Investments accounted for using the equity method, maximum interest	50.00%
Equity method investments included in other assets	$ 46	$ 42
Investments accounted for using the cost method, maximum interest	20.00%
Inventories [Abstract]
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method	75.00%
Property, Plant and Equipment [Line Items]
Selling, general and administrative expenses	$ 5,389	5,400	$ 5,143
Minimum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Maximum \| Buildings
Property, Plant and Equipment [Line Items]
Estimated useful life	40 years
Shipping and Handling
Property, Plant and Equipment [Line Items]
Selling, general and administrative expenses	$ 1,255	$ 1,183	$ 1,140

Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) - Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements	12 Months Ended
	Dec. 31, 2018
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	5 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	40 years

Summary of Significant Accounting Policies - Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Non-service related postretirement costs		$ 87	$ 118	$ 118
Accounting Standards Update 2018-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Tax reform, reclassification from AOCI to retained earnings, tax effect	$ 163
Reclassifying Adjustment \| Accounting Standards Update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Non-service related postretirement costs			$ 118	$ 118
Subsequent Event \| Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, right-of-use assets					$ 450
Operating lease, liabilities					$ 575

Acquisitions and Divestitures - Acquisitions (Details) - USD ($) $ in Millions	1 Months Ended
	Jan. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Goodwill		$ 2,530	$ 2,218
PCA Skin and Elta MD
Business Acquisition [Line Items]
Payments to acquire business	$ 730
Other intangible assets	369
Goodwill	397
Trademarks \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Other intangible assets	$ 231
Useful life	25 years
Customer Relationships \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Other intangible assets	$ 133
Minimum \| Customer Relationships \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Useful life	12 years
Maximum \| Customer Relationships \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Useful life	13 years
North America \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Goodwill	$ 397
Percent of goodwill deductible for tax purposes	45.00%

Acquisitions and Divestitures - Schedule of Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Dec. 31, 2018	Jan. 31, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Goodwill	$ 2,530		$ 2,218
PCA Skin and Elta MD
Business Acquisition [Line Items]
Inventories		$ 8
Other current assets		8
Other intangible assets		369
Goodwill		397
Other current liabilities		(6)
Deferred income taxes		(46)
Fair value of net assets acquired		$ 730

Acquisitions and Divestitures - Divestitures (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land			$ 0	$ 0	$ 60
Gain on sale of land in Mexico			$ 0	$ 0	$ 97
MEXICO
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land	$ 120
Gain on sale of land in Mexico		$ 97
Aftertax gain on sale of land		$ 63
Impact of aftertax gain on sale per common share, diluted (in dollars per share)		$ 0.07
MEXICO \| Third Installment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land	$ 60

Restructuring and Related Implementation Charges - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($) employees	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 88	$ 152	$ 93
Global Growth and Efficiency Program
Restructuring Cost and Reserve [Line Items]
Expected percent of total charges resulting in cash expenditure	80.00%
Pretax charges related to the Restructuring Program to date	$ 1,722
Restructuring and related cost incurred cost to date after tax	1,278
Charges against assets	(27)	(40)	(33)
Total Global Growth and Efficiency Program charges, pretax	$ 161	333	228
Global Growth and Efficiency Program \| Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	10.00%
Global Growth and Efficiency Program \| Corporate
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	40.00%
Global Growth and Efficiency Program \| North America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	15.00%
Global Growth and Efficiency Program \| Europe
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	20.00%
Global Growth and Efficiency Program \| Latin America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Asia Pacific
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	45.00%
Pretax charges related to the Restructuring Program to date	$ 681
Charges against assets	(9)	(21)	(4)
Total Global Growth and Efficiency Program charges, pretax	$ 53	163	61
Global Growth and Efficiency Program \| Incremental Depreciation And Asset Impairment
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	5.00%
Global Growth and Efficiency Program \| Charges Resulting Directly From Exit Activities
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	30.00%
Global Growth and Efficiency Program \| Implementation Of New Strategies
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	20.00%
Global Growth and Efficiency Program \| Third party Incremental Cost
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 42	145	116
Global Growth and Efficiency Program \| Contract Termination
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	48	6	21
Global Growth and Efficiency Program \| Land and Building
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	0	$ 0	$ 1
Global Growth and Efficiency Program \| Minimum \| Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	1,820
Restructuring program total expected cost after tax	1,350
Restructuring program expected cost, upcoming fiscal year, before tax	100
Restructuring program expected cost, upcoming fiscal year, after tax	$ 70
Restructuring and related cost, expected number of positions eliminated (in positions) \| employees	4,000
Global Growth and Efficiency Program \| Maximum \| Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	$ 1,870
Restructuring program total expected cost after tax	1,380
Restructuring program expected cost, upcoming fiscal year, before tax	150
Restructuring program expected cost, upcoming fiscal year, after tax	$ 100
Restructuring and related cost, expected number of positions eliminated (in positions) \| employees	4,400

Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									$ 88	$ 152	$ 93
Global Growth and Efficiency Program
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									161	333	228
Total Global Growth and Efficiency Program charges, aftertax	$ 32	$ 22	$ 51	$ 20	$ 61	$ 39	$ 115	$ 31	125	246	168
Global Growth and Efficiency Program \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 12	$ 8	$ 5	$ 6	$ 24	$ 16	$ 21	$ 14	31	75	46
Global Growth and Efficiency Program \| Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									33	86	77
Global Growth and Efficiency Program \| Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									88	152	93
Global Growth and Efficiency Program \| Non-service related postretirement costs
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									$ 9	$ 20	$ 12

Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) - Global Growth and Efficiency Program	12 Months Ended			75 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	100.00%	100.00%	100.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				100.00%
Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	19.00%	6.00%	7.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				8.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	37.00%	40.00%	23.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				40.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	18.00%	23.00%	35.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				18.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	10.00%	2.00%	5.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				4.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	(2.00%)	21.00%	12.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				20.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	13.00%	5.00%	4.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				4.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	5.00%	3.00%	14.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				6.00%

Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) - Global Growth and Efficiency Program $ in Millions	Dec. 31, 2018 USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 1,722
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	681
Incremental Depreciation
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	92
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	52
Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 897

Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restructuring Reserve [Roll Forward]
Charges	$ 88	$ 152	$ 93
Global Growth and Efficiency Program
Restructuring Reserve [Roll Forward]
Beginning balance	234	181	215
Charges	161	333	228
Cash payments	(167)	(244)	(237)
Charges against assets	(27)	(40)	(33)
Foreign exchange	(4)	4	(1)
Other	5	0	9
Ending balance	202	234	181
Global Growth and Efficiency Program \| Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	127	56	84
Charges	53	163	61
Cash payments	(107)	(74)	(84)
Charges against assets	(9)	(21)	(4)
Foreign exchange	(4)	3	(1)
Other	0	0	0
Ending balance	60	127	56
Global Growth and Efficiency Program \| Incremental Depreciation
Restructuring Reserve [Roll Forward]
Beginning balance	0	0	0
Charges	2	10	9
Cash payments	0	0	0
Charges against assets	(2)	(10)	(9)
Foreign exchange	0	0	0
Other	0	0	0
Ending balance	0	0	0
Global Growth and Efficiency Program \| Asset Impairments
Restructuring Reserve [Roll Forward]
Beginning balance	0	0	0
Charges	16	9	20
Cash payments	0	0	0
Charges against assets	(16)	(9)	(20)
Foreign exchange	0	0	0
Other	0	0	0
Ending balance	0	0	0
Global Growth and Efficiency Program \| Other
Restructuring Reserve [Roll Forward]
Beginning balance	107	125	131
Charges	90	151	138
Cash payments	(60)	(170)	(153)
Charges against assets	0	0	0
Foreign exchange	0	1	0
Other	5	0	9
Ending balance	$ 142	$ 107	$ 125

Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Goodwill [Line Items]
Goodwill	$ 2,530	$ 2,218
Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	2,515	2,203
Pet Nutrition
Goodwill [Line Items]
Goodwill	15	15
North America \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	733	343
Latin America \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	220	256
Europe \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	1,302	1,333
Asia Pacific \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	185	190
Africa/Eurasia \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	$ 75	$ 81

Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Finite and indefinite-lived intangible assets [Line Items]
Finite & indefinite lived intangibles, gross	$ 2,128	$ 1,781
Finite-lived intangible assets, accumulated amortization, net	(491)	(440)
Intangible assets, net (excluding goodwill)	1,637	1,341
Indefinite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	967	985
Trademarks
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	771	547
Finite-lived intangible assets, accumulated amortization, net	(358)	(337)
Finite-lived intangible assets, net	413	210
Other finite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	390	249
Finite-lived intangible assets, accumulated amortization, net	(133)	(103)
Finite-lived intangible assets, net	$ 257	$ 146

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 31, 2018
Goodwill [Line Items]
Goodwill	$ 2,530	$ 2,218
Amortization of intangible assets	59	$ 35	$ 33
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future amortization expense - 2019	50
Future amortization expense - 2020	50
Future amortization expense - 2021	50
Future amortization expense - 2022	50
Future amortization expense - 2023	$ 50
PCA Skin and Elta MD
Goodwill [Line Items]
Goodwill				$ 397
Other intangible assets				369
Trademarks \| PCA Skin and Elta MD
Goodwill [Line Items]
Other intangible assets				231
Customer Relationships \| PCA Skin and Elta MD
Goodwill [Line Items]
Other intangible assets				133
North America \| PCA Skin and Elta MD
Goodwill [Line Items]
Goodwill				$ 397

Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Total Debt	$ 6,354	$ 6,566
Less: Current portion of long-term debt	0	0
Total debt, Excluding current portion of long-term debt	$ 6,354	$ 6,566
Weighted-average interest rate on short term borrowings	5.30%	2.80%
Scheduled maturities of long-term debt [Abstract]
2019	$ 0
2020	249
2021	298
2022	886
2023	893
Thereafter	$ 2,422
Notes
Debt Instrument [Line Items]
Weighted average interest rate	2.80%
Maturity date range, start	Dec. 31, 2019
Maturity date range, end	Dec. 31, 2078
Total Debt	$ 5,820	$ 6,542
Commercial paper
Debt Instrument [Line Items]
Weighted average interest rate	2.50%
Maturity date	2019
Total Debt	$ 534	$ 24

Long-Term Debt and Credit Facilities - Debt Issuances (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Five Year Notes at 2.25 Percent
Schedule of U.S. dollar and Euro denominated notes [Line Items]
Face amount	$ 400
Notes, term	5 years
Fixed interest rate	2.25%
Thirty Year Notes at 3.70 Percent
Schedule of U.S. dollar and Euro denominated notes [Line Items]
Face amount		$ 500
Notes, term		30 years
Fixed interest rate		3.70%

Long-Term Debt and Credit Facilities - Summary of Credit Facilities (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($)
Line of credit facility [Line Items]
Unused borrowing capacity	$ 3,023
Amended Domestic Revolving Credit Facility 2370 Million Capacity
Line of credit facility [Line Items]
Notes, term	5 years
Amended Domestic Revolving Credit Facility 2650 Million Capacity
Line of credit facility [Line Items]
Notes, term	5 years
Maximum borrowing capacity	$ 2,650

Fair Value Measurements and Financial Instruments - Additional Information, Foreign Exchange Risk (Details)	12 Months Ended
	Dec. 31, 2018 country_and_territory
Fair Value Disclosures [Abstract]
Minimum number of countries and territories serving consumers (more than) (in countries and territories)	200

Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Other financial instruments
Total other financial instruments	$ 10	$ 14
Other current assets
Other financial instruments
Marketable securities	10	14
Designated derivative instruments
Designated derivative instruments
Derivative assets	20	25
Derivative liabilities	38	73
Designated derivative instruments \| Interest rate swap contracts \| Other current assets
Designated derivative instruments
Derivative assets	0	0
Designated derivative instruments \| Interest rate swap contracts \| Other accruals
Designated derivative instruments
Derivative liabilities	1	0
Designated derivative instruments \| Interest rate swap contracts \| Other assets
Designated derivative instruments
Derivative assets	0	0
Designated derivative instruments \| Interest rate swap contracts \| Other liabilities
Designated derivative instruments
Derivative liabilities	8	7
Designated derivative instruments \| Foreign currency contracts \| Other current assets
Designated derivative instruments
Derivative assets	20	25
Designated derivative instruments \| Foreign currency contracts \| Other accruals
Designated derivative instruments
Derivative liabilities	8	20
Designated derivative instruments \| Foreign currency contracts \| Other assets
Designated derivative instruments
Derivative assets	0	0
Designated derivative instruments \| Foreign currency contracts \| Other liabilities
Designated derivative instruments
Derivative liabilities	21	46
Designated derivative instruments \| Commodity contracts \| Other current assets
Designated derivative instruments
Derivative assets	0	0
Designated derivative instruments \| Commodity contracts \| Other accruals
Designated derivative instruments
Derivative liabilities	$ 0	$ 0

Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Carrying value of long-term debt	$ 6,354	$ 6,566
Carrying Value
Debt Instrument [Line Items]
Carrying value of long-term debt	6,354	6,566
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 6,434	$ 6,799

Fair Value Measurements and Financial Instruments - Schedule of Fair Value Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Fair Value Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	$ 1,227	$ 2,231
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(3)	(16)
Gain (loss) on hedged items	3	16
Fair Value Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	327	1,231
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(1)	(7)
Gain (loss) on hedged items	1	7
Fair Value Hedging \| Interest rate swap contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	900	1,000
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(2)	(9)
Gain (loss) on hedged items	2	9
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	796	702
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	10	(25)
Gain (loss) reclassified into Cost of sales	(3)	(3)
Cash Flow Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	782	702
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	10	(25)
Gain (loss) reclassified into Cost of sales	(4)	(3)
Cash Flow Hedging \| Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	14	0
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	0
Gain (loss) reclassified into Cost of sales	1	0
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,878	1,079
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	126	(183)
Gain (loss) on hedged items	(126)	183
Net Investment Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	482	478
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	33	(71)
Gain (loss) on hedged items	(33)	71
Net Investment Hedging \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,396	601
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	93	(112)
Gain (loss) on hedged items	$ (93)	$ 112

Capital Stock and Stock-Based Compensation Plans - Narrative (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) $ / shares	Dec. 31, 2016 USD ($) $ / shares	Jun. 18, 2018 USD ($)	May 10, 2013 plan
Preference Stock [Abstract]
Shares authorized (in shares) \| shares	50,262,150
Stock Repurchases [Abstract]
Repurchased stock	$ 1,238	$ 1,399	$ 1,335
Stock-Based Compensation [Abstract]
Number of stockholder approved plans, current \| plan					1
Total stock-based compensation expense charged against pretax income	109	127	123
Total income tax benefit from stock compensation	$ 25	$ 42	$ 40
Weighted-average estimated fair value of stock options granted (in dollars per share) \| $ / shares	$ 9.48	$ 8.37	$ 8.10
Stock-based compensation, additional disclosures [Abstract]
Tax benefit from exercise of stock options and vesting of restricted stock unit awards	$ 12	$ 47	$ 59
Proceeds from exercise of stock options	$ 329	507	386
Incentive Stock Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Number of shares available for grant (in shares) \| shares	9,186,000
Unrecognized compensation expense	$ 45
Unrecognized compensation expense, weighted-average period of recognition in years	2 years 1 month 6 days
Total fair value of shares vested	$ 55	66	61
Stock Option Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Number of shares available for grant (in shares) \| shares	15,604,000
Unrecognized compensation expense	$ 38
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 6 months
Stock-based compensation, additional disclosures [Abstract]
Contractual term (in years)	6 years
Total intrinsic value of options exercised	$ 92	$ 201	$ 221
Program 2018
Stock Repurchases [Abstract]
Stock repurchase program, authorized amount				$ 5,000

Capital Stock and Stock-Based Compensation Plans - Summary of Common Stock and Treasury Stock Activity (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Summary Of Common Stock Activity [Roll Forward]
Common stock balance, January 1 (in shares)	874,701,118	883,108,963	892,738,518
Common stock acquired (in shares)	(18,786,897)	(19,185,828)	(19,271,304)
Shares issued for stock options (in shares)	6,040,920	9,670,988	8,536,639
Shares issued for restricted stock and other (in shares)	957,651	1,106,995	1,105,110
Common stock balance, December 31 (in shares)	862,912,792	874,701,118	883,108,963
Summary Of Treasury Stock Activity [Roll Forward]
Treasury stock balance, January 1 (in shares)	591,005,242	582,597,397	572,967,842
Common stock acquired (in shares)	18,786,897	19,185,828	19,271,304
Shares issued for stock options (in shares)	(6,040,920)	(9,670,988)	(8,536,639)
Shares issued for restricted stock and other (in shares)	(957,651)	(1,106,995)	(1,105,110)
Treasury stock balance, December 31 (in shares)	602,793,568	591,005,242	582,597,397

Capital Stock and Stock-Based Compensation Plans - Fair Value Assumptions (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected term (in years)	4 years 6 months	4 years 6 months	4 years 6 months
Expected volatility rate (in hundredths)	17.70%	16.00%	16.70%
Risk-free rate (in hundredths)	2.80%	1.80%	1.20%
Expected dividend yield (in hundredths)	2.50%	2.20%	2.10%

Capital Stock and Stock-Based Compensation Plans - Summary of Restricted Stock Activity (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2018 $ / shares shares
Summary of restricted stock award activity [Roll Forward]
Restricted stock awards - beginning balance (in shares) \| shares	2,730
Granted (in shares) \| shares	814
Vested (in shares) \| shares	(901)
Forfeited (in shares) \| shares	(169)
Restricted stock awards - ending balance (in shares) \| shares	2,474
Weighted average grant date fair value per award [Roll Forward]
Weighted average grant date fair value of restricted stock awards - beginning of period (in dollars per share) \| $ / shares	$ 70
Weighted average grant date fair value of restricted stock awards - shares granted (in dollars per share) \| $ / shares	69
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share) \| $ / shares	65
Weighted average grant date fair value of restricted stock awards - shares forfeited (in dollars per share) \| $ / shares	70
Weighted average grant date fair value of restricted stock awards - end of period (in dollars per share) \| $ / shares	$ 71

Capital Stock and Stock-Based Compensation Plans - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($) $ / shares shares
Summary of stock option plan activity [Roll Forward]
Options - beginning balance (in shares) \| shares	40,979
Granted (in shares) \| shares	6,290
Exercised (in shares) \| shares	(6,669)
Forfeited or expired (in shares) \| shares	(890)
Options - ending balance (in shares) \| shares	39,710
Options exercisable (in shares) \| shares	26,420
Additional disclosures pertaining to stock options [Abstract]
Weighted average exercise price of options - beginning of period (in dollars per share) \| $ / shares	$ 65
Weighted average exercise price of options - shares granted (in dollars per share) \| $ / shares	68
Weighted average exercise price of options - shares exercised (in dollars per share) \| $ / shares	55
Weighted average exercise price of options - shares forfeited or expired (in dollars per share) \| $ / shares	71
Weighted average exercise price of options - end of period (in dollars per share) \| $ / shares	67
Weighted average exercise price of options exercisable - end of period (in dollars per share) \| $ / shares	$ 66
Weighted average remaining contractual life, options outstanding (in years)	3 years
Weighted average remaining contractual life, options exercisable (in years)	3 years
Value of unexercised in-the-money options, options outstanding \| $	$ 1,457
Value of unexercised in-the-money options, options exercisable \| $	$ 1,457

Employee Stock Ownership Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shares in ESOP (in shares)	15,806,529	18,400,412
Outstanding borrowings in the ESOP	$ 3
Common shares released and allocated to participant accounts (in shares)	13,237,788
Common shares available for future allocation to participant accounts (in shares)	2,568,741
Annual ESOP expense	$ 0	$ 0	$ 0
Dividends paid by the Company on shares held by the ESOP	29	32	35
Company contributions to the ESOP	$ 0	$ 0	$ 0

Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)	Dec. 31, 2018
United States
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	100.00%
United States \| Equity securities
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	22.00%
United States \| Fixed income securities
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	60.00%
United States \| Real estate and other investments
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	18.00%
International
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	100.00%
International \| Equity securities
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	37.00%
International \| Fixed income securities
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	43.00%
International \| Real estate and other investments
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	20.00%

Retirement Plans and Other Retiree Benefits - Additional Information, U.S. Plans (Details) - Pension Plans - United States - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Percentage of investments in Company's common stock	5.00%	7.00%
U.S. plans assets sold to Company (in shares)	384,004	0
U.S. plans assets purchased to Company (in shares)	0	0
Dividends received by plans on the Company’s common stock	$ 3	$ 3

Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Amounts Recognized in Balance Sheet
Current liabilities	$ (84)	$ (81)
Other Retiree Benefit Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	960	923
Service cost	16	13	$ 13
Interest cost	38	40	43
Participants’ contributions	0	0
Acquisitions/plan amendments	0	0
Actuarial loss (gain)	(88)	21
Foreign exchange impact	(5)	3
Termination benefits	0	(3)
Curtailments and settlements	0	0
Benefit payments	(45)	(37)
Other	0	0
Benefit obligations at end of year	876	960	923
Change in Plan Assets
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	(1)	0
Company contributions	100	37
Participants’ contributions	0	0
Foreign exchange impact	0	0
Settlements and acquisitions	0	0
Benefit payments	(45)	(37)
Other	0	0
Fair value of plan assets at end of year	54	0	0
Funded Status
Benefit obligations at end of year	876	960	923
Fair value of plan assets at end of year	54	0	0
Net amount recognized	(822)	(960)
Amounts Recognized in Balance Sheet
Noncurrent assets	0	0
Current liabilities	(46)	(44)
Noncurrent liabilities	(776)	(916)
Net amount recognized	(822)	(960)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	239	338
Transition/prior service cost	(1)	(1)
Amounts recognized in accumulated other comprehensive income	238	337
Accumulated benefit obligation	$ 0	$ 0
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.43%	3.80%
Long-term rate of return on plan assets		6.60%
Long-term rate of compensation increase	3.50%	3.50%
ESOP growth rate	10.00%	10.00%
Medical cost trend rate of increase	6.00%	6.00%
Assumed medical cost trend rates [Abstract]
Medical cost trend rate assumed for next fiscal year	6.00%
Ultimate medical cost trend rate	4.75%
Year which ultimate medical cost trend rate is reached	2024
United States \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 2,363	$ 2,298
Service cost	1	1	1
Interest cost	86	94	105
Participants’ contributions	0	0
Acquisitions/plan amendments	0	0
Actuarial loss (gain)	(139)	110
Foreign exchange impact	0	0
Termination benefits	9	24
Curtailments and settlements	(4)	0
Benefit payments	(169)	(164)
Other	0	0
Benefit obligations at end of year	2,147	2,363	2,298
Change in Plan Assets
Fair value of plan assets at beginning of year	1,812	1,646
Actual return on plan assets	(101)	225
Company contributions	30	105
Participants’ contributions	0	0
Foreign exchange impact	0	0
Settlements and acquisitions	(4)	0
Benefit payments	(169)	(164)
Other	0	0
Fair value of plan assets at end of year	1,568	1,812	1,646
Funded Status
Benefit obligations at end of year	2,147	2,363	2,298
Fair value of plan assets at end of year	1,568	1,812	1,646
Net amount recognized	(579)	(551)
Amounts Recognized in Balance Sheet
Noncurrent assets	0	0
Current liabilities	(26)	(24)
Noncurrent liabilities	(553)	(527)
Net amount recognized	(579)	(551)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	940	911
Transition/prior service cost	1	1
Amounts recognized in accumulated other comprehensive income	941	912
Accumulated benefit obligation	$ 2,090	$ 2,293
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.38%	3.73%
Long-term rate of return on plan assets	6.60%	6.60%
Long-term rate of compensation increase	3.50%	3.50%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%
Long-term rate of return on plan assets [Abstract]
Average annual rates of return for the most recent 1-year period	(5.00%)
Average annual rates of return for the most recent 5-year period	5.00%
Average annual rates of return for the most recent 10-year period	8.00%
Average annual rates of return for the most recent 15-year period	6.00%
Average annual rates of return for the most recent 25-year period	7.00%
International \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 847	$ 800
Service cost	14	16	16
Interest cost	21	22	25
Participants’ contributions	2	2
Acquisitions/plan amendments	4	(6)
Actuarial loss (gain)	(11)	(11)
Foreign exchange impact	(40)	72
Termination benefits	0	0
Curtailments and settlements	(7)	(11)
Benefit payments	(42)	(36)
Other	(1)	(1)
Benefit obligations at end of year	787	847	800
Change in Plan Assets
Fair value of plan assets at beginning of year	575	509
Actual return on plan assets	(16)	42
Company contributions	27	30
Participants’ contributions	3	2
Foreign exchange impact	(29)	40
Settlements and acquisitions	(7)	(11)
Benefit payments	(42)	(36)
Other	(1)	(1)
Fair value of plan assets at end of year	510	575	509
Funded Status
Benefit obligations at end of year	787	847	800
Fair value of plan assets at end of year	510	575	$ 509
Net amount recognized	(277)	(272)
Amounts Recognized in Balance Sheet
Noncurrent assets	6	22
Current liabilities	(12)	(13)
Noncurrent liabilities	(271)	(281)
Net amount recognized	(277)	(272)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	226	209
Transition/prior service cost	6	1
Amounts recognized in accumulated other comprehensive income	232	210
Accumulated benefit obligation	$ 731	$ 787
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	2.80%	2.53%
Long-term rate of return on plan assets	4.06%	4.04%
Long-term rate of compensation increase	2.86%	2.79%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%

Retirement Plans and Other Retiree Benefits - Key Assumptions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Effect of one percentage point increase on accumulated postretirement benefit obligation	$ 115
Effect of one percentage point increase on service and interest cost	10
Effect of one percentage point decrease on accumulated postretirement benefit obligation	(93)
Effect of one percentage point decrease on service and interest cost	$ (7)
Other post-retirement plan, benefit obligation, percent decrease due to expected mortality update in the current year		2.00%
United States \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, benefit obligation, percent decrease due to expected mortality update in current year		1.00%

Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) - Pension Plans - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure - Plans with Projected Obligations in Excess of Plan Assets and Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Line Items]
Projected benefit obligation	$ 2,882	$ 2,834
Fair value of plan assets	2,007	1,992
Accumulated benefit obligation	2,689	2,641
Fair value of plan assets	$ 1,924	$ 1,905

Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Retiree Benefit Plans
Components of Net Periodic Benefit Cost
Service cost	$ 16	$ 13	$ 13
Interest cost	38	40	43
Annual ESOP allocation	0	0	0
Expected return on plan assets	(2)	0	(1)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	14	13	14
Net periodic benefit cost	66	66	69
Other postretirement charges	0	(3)	1
Total pension cost	$ 66	$ 63	$ 70
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	3.80%	4.41%	4.97%
Long-term rate of return on plan assets	6.60%	6.80%	6.80%
Long-term rate of compensation increase	0.00%	0.00%	0.00%
ESOP growth rate	10.00%	10.00%	10.00%
Medical cost trend rate of increase	6.00%	6.33%	6.67%
United States \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	$ 1	$ 1	$ 1
Interest cost	86	94	105
Annual ESOP allocation	0	0	0
Expected return on plan assets	(115)	(111)	(109)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	47	48	41
Net periodic benefit cost	19	32	38
Other postretirement charges	9	24	3
Total pension cost	$ 28	$ 56	$ 41
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	3.73%	4.27%	4.93%
Long-term rate of return on plan assets	6.60%	6.80%	6.80%
Long-term rate of compensation increase	3.50%	3.50%	3.50%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Voluntary contributions to postretirement plans	$ 67	$ 81	$ 53
International \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	14	16	16
Interest cost	21	22	25
Annual ESOP allocation	0	0	0
Expected return on plan assets	(21)	(22)	(23)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	8	10	8
Net periodic benefit cost	22	26	26
Other postretirement charges	2	4	11
Total pension cost	$ 24	$ 30	$ 37
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	2.53%	2.59%	3.17%
Long-term rate of return on plan assets	4.04%	4.14%	4.62%
Long-term rate of compensation increase	2.79%	2.58%	2.78%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Global Growth and Efficiency Program
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Charges against assets	$ 27	$ 40	$ 33
Global Growth and Efficiency Program \| Employee-Related Costs
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Charges against assets	$ 9	$ 21	$ 4

Retirement Plans and Other Retiree Benefits - Summary of Amounts in AOCI (Details) $ in Millions	Dec. 31, 2018 USD ($)
Pension Plans
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	$ 60
Net transition and prior service cost	0
Other Retiree Benefit Plans
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	11
Net transition and prior service cost	$ 0

Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Estimated future voluntary employer contributions in next fiscal year	$ 100
Expected benefit payments from company assets	61
Total benefit payments [Abstract]
2019	231
2020	228
2021	232
2022	235
2023	240
2024-2028	1,209
Other Retiree Benefit Plans
Total benefit payments [Abstract]
2019	47
2020	47
2021	48
2022	48
2023	49
2024-2028	256
United States \| Pension Plans
Total benefit payments [Abstract]
2019	149
2020	146
2021	147
2022	151
2023	151
2024-2028	736
International \| Pension Plans
Total benefit payments [Abstract]
2019	35
2020	35
2021	37
2022	36
2023	40
2024-2028	$ 217

Income Taxes - Components of Income Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
United States	$ 1,175	$ 1,072	$ 1,191
International	2,289	2,415	2,547
Income before income taxes	$ 3,464	$ 3,487	$ 3,738

Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
United States	$ 248	$ 338	$ 395
International	658	975	757
Total Provision for income taxes	$ 906	$ 1,313	$ 1,152

Income Taxes - Income Tax Provision Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Goodwill and intangible assets	$ 2	$ 135	$ 18
Property, plant and equipment	(15)	84	(3)
Pension and other retiree benefits	(7)	(192)	0
Stock-based compensation	9	(28)	15
Tax credits and tax loss carryforwards	(4)	(4)	5
Deferred withholding tax	(100)	(119)	0
Other, net	62	16	(106)
Total deferred tax benefit (provision)	$ (53)	$ (108)	$ (71)

Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017	Mar. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Line Items]
Tax at United States statutory rate				21.00%	35.00%	35.00%
State income taxes, net of federal benefit				1.00%	0.50%	0.50%
Earnings taxed at other than United States statutory rate				4.50%	(3.40%)	(2.70%)
Charge for U.S. tax reform				2.30%	7.90%	0.00%
Excess tax benefits from stock-based compensation				(0.30%)	(1.40%)	0.00%
Foreign Tax Credit Carryback				(1.70%)	0.00%	0.00%
(Benefit) charge for previously disclosed tax matters				(0.40%)	0.00%	(0.80%)
(Benefit) on Venezuela remeasurement				0.00%	0.00%	(5.60%)
Tax charge on incremental repatriation of foreign earnings				0.00%	0.00%	5.60%
Other, net				(0.20%)	(0.90%)	(1.20%)
Effective tax rate				26.20%	37.70%	30.80%
Tax reform, provisional charge	$ 80	$ 275		$ 80	$ 275	$ 0
Tax benefit from exercise of stock options and vesting of restricted stock unit awards				$ 12	$ 47	59
CP Venezuela
Income Taxes [Line Items]
Income tax benefit, principally related to changes in Venezuela foreign currency regime			$ 210
Foreign earnings repatriated						$ 1,500
Tax charge resulting from repatriation of earnings of foreign subsidiaries			$ 210

Income Taxes - Components of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Deferred tax liabilities:
Goodwill and intangible assets	$ (344)	$ (311)
Property, plant and equipment	(311)	(306)
Deferred withholding tax	(181)	(119)
Other	(75)	(63)
Deferred tax liabilities, total	(911)	(799)
Deferred tax assets:
Pension and other retiree benefits	354	375
Tax credits and tax loss carryforwards	89	48
Accrued liabilities	180	197
Stock-based compensation	95	90
Other	164	82
Total deferred tax assets	882	792
Valuation Allowance	(54)	(9)
Deferred tax assets, total	828	783
Assets:
Deferred income taxes	152	188
Liabilities:
Deferred income taxes	(235)	(204)
Net deferred income taxes	$ (83)	$ (16)

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Line Items]
Income tax expense (benefit) allocated directly to equity	$ (2)	$ (37)	$ (85)
Unrecognized tax benefits that would impact effective tax rate	180
Cash outflow from unrecognized tax benefit that would impact effective tax rate	186
Interest (income) expense recognized related to unrecognized tax benefits	(1)	11	2
Accrued interest related to unrecognized tax benefits	$ 27	$ 28	$ 17
Minimum
Income Taxes [Line Items]
Statue of limitations on foreign jurisdictions for tax audits	3 years
Maximum
Income Taxes [Line Items]
Statue of limitations on foreign jurisdictions for tax audits	6 years

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Unrecognized tax benefits:
Balance, January 1	$ 214	$ 201	$ 186
Increases as a result of tax positions taken during the current year	14	13	9
Decreases of tax positions taken during prior years	(37)	(9)	(45)
Increases of tax positions taken during prior years	9	15	71
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(6)	(15)	(18)
Effect of foreign currency rate movements	(4)	9	(2)
Balance, December 31	$ 190	$ 214	$ 201

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income [Abstract]
Basic EPS									$ 2,400	$ 2,024	$ 2,441
Diluted EPS									$ 2,400	$ 2,024	$ 2,441
Shares [Abstract]
Basic EPS (in shares)									870,600,000	881,800,000	891,800,000
Stock options and restricted stock units (in shares)									2,400,000	6,000,000	6,600,000
Diluted EPS (in shares)									873,000,000	887,800,000	898,400,000
Earnings Per Share, Basic [Abstract]
Basic EPS (in dollars per share)	$ 0.70	$ 0.60	$ 0.73	$ 0.72	$ 0.37	$ 0.69	$ 0.59	$ 0.64	$ 2.76	$ 2.30	$ 2.74
Earnings Per Share, Diluted [Abstract]
Diluted EPS (in dollars per share)	$ 0.70	$ 0.60	$ 0.73	$ 0.72	$ 0.37	$ 0.68	$ 0.59	$ 0.64	$ 2.75	$ 2.28	$ 2.72
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)									18,039,961	11,056,725	3,187,485
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)									9,529	91	2,693

Commitments and Contingencies (Details) $ in Millions	1 Months Ended		12 Months Ended
Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2015 appeal	Dec. 31, 2014 USD ($) company	Dec. 31, 2018 USD ($) country_and_territory case	Dec. 31, 2017 USD ($) case	Dec. 31, 2016 USD ($)	Jul. 31, 2017 USD ($)
Operating leases,minimum rental commitments[Abstract]
Minimum rental commitments under noncancellable operating leases due within one year of the balance sheet date			$ 193
Minimum rental commitments under noncancellable operating leases due in two years of the balance sheet date			165
Minimum rental commitments under noncancellable operating leases due in three years of the balance sheet date			123
Minimum rental commitments under noncancellable operating leases due in four years of the balance sheet date			102
Minimum rental commitments under noncancellable operating leases due in five years of the balance sheet date			51
Minimum rental commitments under noncancellable operating leases due after five years of the balance sheet date			32
Operating leases, rental expense [Abstract]
Rental expense			213	$ 211	$ 204
Contractual commitments (Abstract)
Contractual commitments, amount			$ 440
Contingencies [Abstract]
Minimum number of countries and territories serving consumers (more than) (in countries and territories) \| country_and_territory			200
Brazilian internal revenue authority, matter 1			$ 151
Loss contingency, number of appeals lost (in appeals) \| appeal	1
Brazilian internal revenue authority, matter 2			$ 65
Number of consumer goods companies \| company		13
Fine imposed French competition authority		$ 57
Fine imposed French competition authority - as a result of Sanex Acquisition		$ 25
Fine imposed by greek competition authority						$ 11
Loss contingency, pending claims, number (in cases) \| case			239	193
Loss contingency, new claims filed, number (in cases) \| case			132
Loss contingency, claims dismissed or settled, number (in cases) \| case			86
Minimum
Contingencies [Abstract]
Range of reasonably possible losses			$ 0
Maximum
Contingencies [Abstract]
Range of reasonably possible losses			$ 225

Segment Information - Narrative (Details) $ in Millions	3 Months Ended	12 Months Ended
Segment Information - Narrative (Details) $ in Millions	Sep. 30, 2016 USD ($)	Dec. 31, 2018 USD ($) business_segment	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of product segments (in segments) \| business_segment		2
Number of reportable segments (in segments) \| business_segment		5
Number of operating segments (in segments) \| business_segment		5
Non-service related postretirement costs		$ 87	$ 118	$ 118
Total Global Growth and Efficiency Program charges, pretax		88	152	93
Charges for a litigation matter		0	0	17
Gain on sale of land in Mexico		0	0	97
Operating Segments \| Pet Nutrition
Segment Reporting Information [Line Items]
Non-service related postretirement costs			24	24
Corporate
Segment Reporting Information [Line Items]
Non-service related postretirement costs			20	21
North America \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Non-service related postretirement costs			57	57
Latin America \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Non-service related postretirement costs			9	7
Europe \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Non-service related postretirement costs			6	7
Asia Pacific \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Non-service related postretirement costs			1	1
Africa/Eurasia \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Non-service related postretirement costs			1	1
MEXICO
Segment Reporting Information [Line Items]
Gain on sale of land in Mexico	$ 97
Global Growth and Efficiency Program
Segment Reporting Information [Line Items]
Total Global Growth and Efficiency Program charges, pretax		$ 161	333	228
Sales Revenue, Net
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US		70.00%
Percentage of consolidated Net sales coming from emerging markets		50.00%
Percentage of consolidated sales represented by one customer		11.00%
Reclassifying Adjustment \| Accounting Standards Update 2017-07
Segment Reporting Information [Line Items]
Non-service related postretirement costs			118	118
Operating Profit
Segment Reporting Information [Line Items]
Charges for a litigation matter				17
Operating Profit \| MEXICO
Segment Reporting Information [Line Items]
Gain on sale of land in Mexico				(97)
Operating Profit \| Global Growth and Efficiency Program
Segment Reporting Information [Line Items]
Total Global Growth and Efficiency Program charges, pretax		$ 152	$ 313	$ 216

Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Net sales	$ 3,811	$ 3,845	$ 3,886	$ 4,002	$ 3,892	$ 3,974	$ 3,826	$ 3,762	$ 15,544	$ 15,454	$ 15,195
Operating profit									3,694	3,707	3,955
Capital expenditures									436	553	593
Depreciation and amortization									511	475	443
Assets	$ 12,161				$ 12,676				$ 12,161	$ 12,676	$ 12,123
Percentage of corporate identifiable assets consisting of derivative instruments	7.00%				5.00%				7.00%	5.00%	24.00%
Percentage of corporate identifiable assets consisting of investments in equity securities	88.00%				86.00%				88.00%	86.00%	68.00%
Total long lived assets	$ 8,259				$ 7,908				$ 8,259	$ 7,908	$ 7,642
Oral, Personal and Home Care \| United States
Segment Reporting Information [Line Items]
Net sales									3,091	2,865	2,932
Pet Nutrition \| United States
Segment Reporting Information [Line Items]
Net sales									1,304	1,246	1,243
Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales									13,156	13,162	12,931
Operating profit									3,616	3,841	3,887
Capital expenditures									309	402	433
Depreciation and amortization									351	323	297
Assets	11,068				11,600				11,068	11,600	11,058
Operating Segments \| Oral, Personal and Home Care \| North America
Segment Reporting Information [Line Items]
Net sales									3,348	3,117	3,183
Operating profit									1,037	1,043	1,087
Capital expenditures									53	74	151
Depreciation and amortization									88	58	54
Assets	3,310				2,608				3,310	2,608	2,685
Operating Segments \| Oral, Personal and Home Care \| Latin America
Segment Reporting Information [Line Items]
Net sales									3,605	3,887	3,650
Operating profit									995	1,171	1,139
Capital expenditures									131	127	94
Depreciation and amortization									82	82	76
Assets	2,225				2,423				2,225	2,423	2,314
Operating Segments \| Oral, Personal and Home Care \| Europe
Segment Reporting Information [Line Items]
Net sales									2,502	2,394	2,342
Operating profit									634	605	586
Capital expenditures									39	63	51
Depreciation and amortization									70	74	64
Assets	2,883				3,781				2,883	3,781	3,554
Operating Segments \| Oral, Personal and Home Care \| Asia Pacific
Segment Reporting Information [Line Items]
Net sales									2,734	2,781	2,796
Operating profit									777	842	888
Capital expenditures									75	125	120
Depreciation and amortization									103	101	96
Assets	2,148				2,244				2,148	2,244	2,006
Operating Segments \| Oral, Personal and Home Care \| Africa/Eurasia
Segment Reporting Information [Line Items]
Net sales									967	983	960
Operating profit									173	180	187
Capital expenditures									11	13	17
Depreciation and amortization									8	8	7
Assets	502				544				502	544	499
Operating Segments \| Pet Nutrition
Segment Reporting Information [Line Items]
Net sales									2,388	2,292	2,264
Operating profit									680	677	677
Capital expenditures									35	33	38
Depreciation and amortization									53	53	53
Assets	1,033				1,026				1,033	1,026	1,009
Corporate
Segment Reporting Information [Line Items]
Operating profit									(602)	(811)	(609)
Capital expenditures									92	118	122
Depreciation and amortization									107	99	93
Assets	$ 60				$ 50				$ 60	$ 50	$ 56

Supplemental Income Statement Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other (income) expense, net
Total Global Growth and Efficiency Program charges, pretax	$ 88	$ 152	$ 93
Amortization of intangible assets	59	35	33
Gain on sale of land in Mexico	0	0	(97)
Charges for a litigation matter	0	0	17
Equity income	(10)	(11)	(10)
Other, net	11	(3)	(11)
Total Other (income) expense, net	148	173	25
Interest (income) expense, net
Interest incurred	195	156	155
Interest capitalized	(2)	(3)	(6)
Interest income	(50)	(51)	(50)
Total Interest (income) expense, net	143	102	99
Research and development	277	285	289
Advertising	$ 1,590	$ 1,573	$ 1,428

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Inventory, Net [Abstract]
Raw materials and supplies	$ 253	$ 267
Work-in-process	37	42
Finished goods	960	912
Total Inventories	1,250	1,221
Inventories valued under LIFO	294	289
Excess of current cost over LIFO cost	63	63
Property, plant and equipment, net
Land	152	159
Buildings	1,604	1,655
Manufacturing machinery and equipment	5,157	5,165
Other equipment	1,423	1,481
Property, plant and equipment, gross	8,336	8,460
Accumulated depreciation	(4,455)	(4,388)
Total Property, plant and equipment, net	3,881	4,072
Other accruals
Accrued advertising and coupon redemption	486	510
Accrued payroll and employee benefits	275	325
Accrued taxes other than income taxes	127	123
Restructuring accrual	148	181
Pension and other retiree benefits	84	81
Accrued interest	35	34
Derivatives	9	20
Other	532	557
Total Other accruals	1,696	1,831
Other liabilities
Pension and other retiree benefits	1,600	1,724
Restructuring accrual	54	53
Other	380	478
Total Other liabilities	$ 2,034	$ 2,255

Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total Other comprehensive income (loss), net of tax	$ (189)	$ 342	$ (242)
Cumulative translation adjustments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), Pretax	(233)	218	(97)
Total Other comprehensive income (loss), net of tax	(218)	285	(125)
Pension and other benefits
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	(21)	21	(231)
Reclassification from AOCI, Pretax	69	71	63
Other comprehensive income (loss), Pretax	48	92	(168)
Other comprehensive income (loss), before reclassifications, Net of Tax	(16)	9	(152)
Reclassification from AOCI, Net of Tax	54	45	43
Total Other comprehensive income (loss), net of tax	38	54	(109)
Available-for-sale securities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from AOCI, Pretax	0	0	(1)
Other comprehensive income (loss), Pretax	0	0	(1)
Reclassification from AOCI, Net of Tax	0	0	(1)
Total Other comprehensive income (loss), net of tax	0	0	(1)
Cash flow hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, Pretax	10	(25)	11
Reclassification from AOCI, Pretax	3	3	(4)
Other comprehensive income (loss), Pretax	13	(22)	7
Other comprehensive income (loss), before reclassifications, Net of Tax	8	(16)	8
Reclassification from AOCI, Net of Tax	2	2	(3)
Total Other comprehensive income (loss), net of tax	10	(14)	5
Accumulated Other Comprehensive Income (Loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), Pretax	(172)	288	(259)
Total Other comprehensive income (loss), net of tax	$ (170)	$ 325	$ (230)

Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Equity [Abstract]
Unrecognized pension and other retiree benefit costs, aftertax	$ 1,038	$ 923
Foreign currency translation adjustments	$ 3,155	$ 2,927

Quarterly Financial Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly financial data (Unaudited) [Abstract]
Net sales	$ 3,811	$ 3,845	$ 3,886	$ 4,002	$ 3,892	$ 3,974	$ 3,826	$ 3,762	$ 15,544	$ 15,454	$ 15,195
Gross profit	2,253	2,269	2,301	2,408	2,328	2,383	2,300	2,269	9,231	9,280	9,123
Net income including noncontrolling interests	643	562	675	678	353	650	560	611	2,558	2,174	2,586
Net income attributable to Colgate-Palmolive Company	$ 606	$ 523	$ 637	$ 634	$ 323	$ 607	$ 524	$ 570	$ 2,400	$ 2,024	$ 2,441
Earnings (loss) per common share:
Basic EPS (in dollars per share)	$ 0.70	$ 0.60	$ 0.73	$ 0.72	$ 0.37	$ 0.69	$ 0.59	$ 0.64	$ 2.76	$ 2.30	$ 2.74
Diluted EPS (in dollars per share)	$ 0.70	$ 0.60	$ 0.73	$ 0.72	$ 0.37	$ 0.68	$ 0.59	$ 0.64	$ 2.75	$ 2.28	$ 2.72
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax									$ 88	$ 152	$ 93
Charge for U.S. tax reform		$ 80			$ 275				80	275	0
Benefit from a foreign tax matter			$ 15						(15)
Global Growth and Efficiency Program
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax									161	333	228
Total Global Growth and Efficiency Program charges, including noncontrolling interest, aftertax	$ 34		48						124
Total Global Growth and Efficiency Program charges, aftertax	32	22	51	$ 20	61	$ 39	$ 115	$ 31	125	246	168
Global Growth and Efficiency Program \| Gross Profit
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax	$ 12	$ 8	$ 5	$ 6	$ 24	$ 16	$ 21	$ 14	$ 31	$ 75	$ 46

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Allowance for doubtful accounts and estimated returns
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance of valuation allowance and reserves	$ 77	$ 73	$ 59
Charged to Costs and Expenses, additions	15	8	18
Other, additions	0	0	0
Deductions	10	4	4
Ending balance of valuation allowance and reserves	82	77	73
Valuation allowance for deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance of valuation allowance and reserves	9	0	0
Charged to Costs and Expenses, additions	45	9	0
Other, additions	0	0	0
Deductions	0	0	0
Ending balance of valuation allowance and reserves	$ 54	$ 9	$ 0

Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Percent of fixed income assets invested in US treasury or agency securities	50.00%	50.00%
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 54	$ 0	$ 0
Other Retiree Benefit Plans \| Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	36	0
Other Retiree Benefit Plans \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18	0
Other Retiree Benefit Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	0
Other Retiree Benefit Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3	0
Other Retiree Benefit Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4	0
Other Retiree Benefit Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	28	0
Other Retiree Benefit Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Domestic, developed and emerging markets equity funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8	0
Other Retiree Benefit Plans \| Fixed income funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4	0
Other Retiree Benefit Plans \| Hedge funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	0
Other Retiree Benefit Plans \| Multi-Asset funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3	0
Other Retiree Benefit Plans \| Real estate funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	0
Other Retiree Benefit Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,568	1,812	1,646
United States \| Pension Plans \| Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,076	1,130
United States \| Pension Plans \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	534	707
United States \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	29	21
United States \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	75	127
United States \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	106	138
United States \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	865	843
United States \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	1
United States \| Pension Plans \| Domestic, developed and emerging markets equity funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	229	350
United States \| Pension Plans \| Fixed income funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	116	122
United States \| Pension Plans \| Hedge funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	56	82
United States \| Pension Plans \| Multi-Asset funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	94	115
United States \| Pension Plans \| Real estate funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	39	38
United States \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(42)	(25)
International \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	510	575	$ 509
International \| Pension Plans \| Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	173	189
International \| Pension Plans \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	337	386
International \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	9	11
International \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3	4
International \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4	3
International \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	82	94
International \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	24	24
International \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	51	53
International \| Pension Plans \| Domestic, developed and emerging markets equity funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	134	189
International \| Pension Plans \| Fixed income funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	173	167
International \| Pension Plans \| Hedge funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6	5
International \| Pension Plans \| Multi-Asset funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	3
International \| Pension Plans \| Real estate funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	22	22
International \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0	$ 0